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Summary
This is the fifth national monitoring report for the BreastScreen Australia Program. The third
and fourth reports have been combined in the BreastScreen Australia Monitoring Report
19981999 and 19992000, which is available as an internet-only publication on the
Australian Institute of Health and Welfares web site (http://www.aihw.gov.au). This
fifth report presents statistics on BreastScreen Australia screening activity and outcomes
for 20002001. A reporting interval of two years is used because it corresponds with the
recommended interval between screens for asymptomatic women in the target age group of
5069 years.
Participation
 In 20002001, 1,567,544 women participated in BreastScreen Australia screening. Of
these women, 1,063,479 (68%) were in the screening program target age group of
5069 years.
 Between the periods 19992000 and 20002001 the proportion of women in the target
population (women aged 50 to 69 years) participating in the BreastScreen Australia
Program rose from 55.9% to 56.9%.
 Although there was some variation in participation rates among different
socioeconomic groups, the difference between the most and the least disadvantaged
groups was only marginally significant, and all groups had participation rates above
55%. Greater variation in participation rates was observed for different cultural and
linguistic groups. At 36.2%, the age-standardised participation rate for Indigenous
women in the target age group was significantly lower than both the national
participation rate and the participation rate for non-Indigenous women.
Detection of cancer
 In order to reduce morbidity and mortality resulting from breast cancer, BreastScreen
Australia aims to maximise the early detection of small-diameter (15 mm or less)
invasive breast cancers. In 2001, 65% of all invasive breast cancers detected by
BreastScreen Australia were small-diameter cancers. This proportion was reduced to
56.4% for women who were attending for their first screen and increased to 66.6% for
women who had previously been screened.
 For women in the target age group, the age-standardised rate of small-diameter invasive
cancer detection was 29 per 10,000 women screened in 2001. This was not significantly
different from the 2000 rate of 29.6 per 10,000 women screened.
 Across the states and territories the age-standardised rates of interval cancer (that is, an
invasive cancer detected between two screening rounds, see glossary) for women in the
target age group in the 24 months after their first screen ranged from 5.6 per 10,000
women-years in the Australian Capital Territory to 14.5 per 10,000 women-years in
Tasmania.
 Program sensitivity is the proportion of invasive breast cancers that are detected
within the BreastScreen Australia Program out of all invasive breast cancers (interval
cancers plus screen-detected cancers) diagnosed in program-screened women in the
screening interval. The Program sensitivity rate for women in the target age group
ranged from 68.2% in Tasmania to 81.3% in Western Australia.
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 In 2001, 883 cases of ductal carcinoma in situ were detected in women participating in
the BreastScreen Australia Program. The age-standardised detection rate for this
condition was 11.2 per 10,000 women screened for women in the target age group and
10.4 per 10,000 women screened for all women aged 40 and over.
Recall for assessment
 The proportion of women recalled for assessment because of an abnormal mammogram
result was significantly higher for women being screened for the first time in 2001
compared with women who had previously been screened. The age-standardised recall
rate was 8.3% for women attending their first round of screening. For women attending
for their second or subsequent screen, only 4.0% (age-standardised) were recalled for
assessment because of an abnormal result.
Rescreening
 The proportion of women attending a BreastScreen Australia service in 1999 and
returning for rescreening within the recommended 27-month interval increased with the
number of previous screens. The age-standardised national rescreen rate for women
attending a BreastScreen Australia service in 1999 for the first time was 64.7%. The
rescreen rate increased to 75% for women attending for their second screen and 82.5%
for women attending for a third or subsequent screen within 27 months.
Breast cancer incidence
 With some fluctuation, there was a notable increase between 1987 and 2000 in the age-
standardised breast cancer incidence rates for women in the target age group. Incidence
increased in the target age group from 197.1 new cancers per 100,000 women in 1987 to
296.9 per 100,000 women in 2000.
 Of the 11,316 new cases of breast cancer in 2000, 5,452 (48%) occurred in women in the
target age group. Only 6% of cases were women aged under 40 years. Age-specific
incidence rates in 2000 ranged from 115.2 new cancers per 100,000 women in the
4044 age group to 337.4 new cases per 100,000 women in the 6064 age group.
Breast cancer mortality
 From 1993 onwards, a steady decline is evident in the age-standardised mortality rates
for women in the target age group. The mortality rate for these women was 66.8 deaths
per 100,000 women in 1988; in 2001, the corresponding figure was 51.8. A similar pattern
of decline in mortality rates can be observed in women aged 70 and over. Mortality rates
for women aged under 50 years remained the lowest and most consistent, staying below
8 deaths per 100,000 women for the period 1987 to 2001.

1Introduction
This report on the performance of the BreastScreen Australia Program during 2000 and 2001
marks an important anniversary. Australias national mammographic screening program
was established in 1991, so it has now been operating for over 10 years, delivering quality
breast cancer screening services to Australian women.
By the mid-1980s there was a growing body of international evidence that an organised
approach to mammography screening would result in a significant decrease in breast cancer
mortality. Towards the end of the 1980s a number of small private and public sector breast
screening services had been established in Australia.
In November 1987, the Australian Health Ministers Advisory Council endorsed a
recommendation to establish a National Breast Cancer Screening Evaluation study to assess
the feasibility and cost-effectiveness of establishing a national breast cancer screening
program. Specifically, the evaluation was to assess the possibility of providing high-quality
services that were acceptable and accessible to women and that represented value for
money. The Commonwealth committed $3.1 million over three years to this joint initiative
with the state and territory health departments; additional funding of $2.8 million was
provided for mobile screening units in 198990.
The National Breast Cancer Screening Evaluation was overseen by the Breast Cancer
Screening Steering Committee, which provided advice on a range of pilot projects and their
evaluation. The Steering Committee was supported by the Screening Evaluation
Co-ordination Unit, established at the then Australian Institute of Health.
The National Breast Cancer Screening Evaluation included 11 breast cancer screening units,
some of which were pre-existing and others being established as part of the evaluation. Both
public and private screening units were included in the evaluation, from all states and
territories except Tasmania. The aim of the evaluation was to establish whether breast cancer
screening could be effectively implemented in Australia and achieve the screening
participation rates and results obtained in other countries.
In 1990 the Screening Evaluation Co-ordination Unit provided its report, Breast cancer
screening in Australia: future directions, to the Australian Health Ministers Advisory Council.
The report covered the epidemiological basis for and cost-effectiveness of introducing an
organised breast cancer screening program in Australia. It also examined the acceptability of
screening to Australian women and whether the Australian health system had the capacity
to deliver screening. Finally, it discussed and made detailed recommendations about the
policy aspects of developing a national screening program. These included the parameters
for eligibility for screeningin particular, identifying the target age groupand the
screening interval. Other important components were providing a foundation for quality
assurance across the breast cancer screening pathway, ensuring equal access, and
maintaining the involvement of general practitioners. The report also stressed the
importance of continued monitoring and evaluation of the screening program over time. It
noted that there was sufficient evidence to support the development of a national screening
program, and it provided the basis for the development of the National Program for the
Early Detection of Breast Cancer.
2Promoting breast cancer screening
In 199495, the Commonwealth committed funding over five years towards the development of a social
marketing campaign, including the mass media, to inform women about the breast cancer screening
program and to promote the benefits of early detection to reduce deaths and illness from breast cancer.
In 1995 Sara Henderson, the well-known Northern Territory cattle-station owner, author and
motivational speaker became the figurehead of the BreastScreen Australia campaign. The Sara Henderson
campaign concept and advertising materials included television and radio commercials, magazine and
press advertisement, and supporting promotional material.
Campaign media activity has included a mix of metropolitan and regional television advertising and
magazine and community radio advertising. Some campaign activity has specifically sought to target
women from non-English speaking backgrounds via SBS Television and community radio. General
practitioners have also been targeted with specific information dissemination strategies. BreastScreen
Australia advertising material was included in the 199899 Essentials GP Patient Counselling Kit and
tear-out leaflets on breast cancer screening were sponsored by BreastScreen Australia to provide patients
with information about the benefits of screening.
Since the campaign began in 1995 various public relations activities have been implemented to support it.
These have played an important role in building on and reinforcing messages to the target audience.
Some of the main activities have been:
 placing editorials in newspapers and magazines;
 community service announcements on SBS Television and community radio;
 distributing posters and brochures in general practitioners surgeries and health centres;
 distributing program information and bookmarks to libraries;
 promoting the campaign through Sara Hendersons book tour in 1995;
 promoting the program in the media; and
 developing the 13 20 50 information phone line and internet site.
In 1990, the Commonwealth announced funding of $64 million over three years to
implement a national program for the early detection of breast cancer, based on the
recommendations in the Screening Evaluation Co-ordination Unit report. The program was
jointly funded by the Commonwealth and the states and territories and was to be phased in
over five years.
The National Advisory Committee for the Early Detection of Breast Cancer was established
in 1991. Its role was to provide advice relating to implementation of the National Program.
The early 1990s focused on a range of activities related to implementing a national breast
cancer screening program. The Commonwealth established a National Coordination Unit
collaborating with the states and territories to develop and implement policies, funding
formulae, quality management infrastructure, processes and organisational systems. The
states and territories established State Coordination Units and developed five-year plans for
the systematic implementation of breast cancer screening and assessment services tailored to
the state or territorys health system and environment. The State Coordination Units also
provided critical input at the national level to the policies and protocols that would guide
the breast cancer screening program and provide for a consistent, truly national program.
The following are among the achievements of that early period:
• the development of national minimum accreditation guidelines and an accreditation
system to ensure that breast cancer Screening and Assessment Services were providing
3high-quality, effective services to women. The guidelines were replaced by the National
Accreditation Requirements in 1994;
• establishment of a national minimum data set;
• establishment and operation of state and territory data systems to ensure that women
received appropriate follow-up and to enable monitoring and evaluation of the Program;
• a summary of the major age-related issues in breast cancer screening and an information
statement about the efficacy of screening mammography for women of various age
groups;
• multi-disciplinary and uni-disciplinary training packages were developed by the
Commonwealth in collaboration with the state and territory Programs. Training
programs were offered at the national and state and territory levels for all clinical and
non-clinical staff working in the Program;
• examination of issues related to the inclusion of open biopsy in the Program;
• exploration of medico-legal considerations; and
• establishment of a national freecall number for the Program13 20 50to support
appointment and information processes for women.
In 1996, the name of the Program was changed to BreastScreen Australia and the National
Advisory Committee was reconstituted. To celebrate the achievements of the Program, a
National Breast Cancer Conference was held in 1997. Since that time, the National Advisory
Committee has been working on refining BreastScreen Australia policies and national
activities. The following have been important achievements:
• collection and publication of data against agreed national performance measures;
• review of the National Accreditation Requirements and endorsement of the new
BreastScreen Australia National Accreditation Standards;
• development of a transparent and consistent tool to support accreditation decision
making;
• the BreastScreen Australia Evaluation Plan agreed and the first project under that plan,
the, BreastScreen Australia Data Dictionary, completed;
• development of a BreastScreen Australia Monitoring Plan;
• research on the BreastScreen Australia Radiographer and Radiologist workforces;
• issuing of BreastScreen Australia National Information Statements;
• agreement on a strategy for increasing the participation of Aboriginal and Torres Strait
Islander women in breast cancer screening, based on broad consultation with Indigenous
women and organisations;
• agreement on a BreastScreen Australia National Data Policy; and
• adoption of the BreastScreen Australia National Policy Framework on Symptomatic
Women.
However, the greatest achievement in the period from 1996 to 2001 is that the BreastScreen
Australia Program has provided over 4.5 million screening mammograms. During that
period, the program has also consistently maintained cancer detection rates and detection
rates for small cancers at or above those set as minimum standards for services to achieve.
4Providing services in rural and remote areas
The BreastScreen Australia Program has developed some innovative approaches to ensuring that women in
rural and remote areas have access to screening and assessment services. A network of 46 mobile screening
units currently operates in over 500 locations throughout the country.
To provide access to women living in some of the most remote regions of Australia it has been necessary to
purpose-build four-wheel-drive trucks that enable the transport of mammography equipment by road and
barge. To ensure that services are available to women in the Torres Strait Islands, for example, a four-
wheel-drive truck requires three separate barge tripsthe first from the mainland coast by landing barge to
the coastal freighter (where the transfer of the truck from one vessel to the other happens at sea), the second
to Thursday Island, and the third from Thursday Island to the outer islands.
The staff of BreastScreen Australia take special care to ensure that visits to rural communities are
successful. Before the mobile unit arrives, the recruitment and promotional staff visit to conduct publicity
drives, provide training for local health workers and general practitioners, and check the proposed
screening site, power and other technical requirements as well as access for equipment, clients and staff.
For most women who attend for breast cancer screening, their result will be normal, with no cancer
detected. For some women, however, abnormalities that require further assessment will be detected.
To enable rural women to attend BreastScreen Australia assessment services, the states and territories
operate a travel subsidy scheme, which assists with the cost of travel and accommodation for women and,
in some cases, their carers.
Many rural communities have become strong partners in providing support for visits of the BreastScreen
Australia mobile units. In Queensland, for example, a team of trained volunteers from the Queensland
Country Womens Association and The Older Womens Network help women fill out their forms when
they arrive for their screening appointments. BreastScreen Australia recognises the value of community
partnership, and activities such as these help ensure a high participation rate. In 20012002, 61% of
eligible Queensland women living in rural, remote and regional areas participated in the Program; this
compares with only 55% of urban women in the south-east corner of the state.
Since the introduction of the national breast cancer screening program, there has been a
23.7% reduction in female deaths from breast cancer1 in the target age range of 5069 years.
The survival rate five years after diagnosis of breast cancer increased from 72.3% during
1982 to 1986 to 84.0% between 1992 and 1997. These encouraging results can be attributed to
early detection through screening combined with improvements in treatment and drug
therapies. Nevertheless, breast cancer remains a major health concern for Australian women.
More women die from it than from any other form of cancer: in 2001 it caused the death of
2,585 Australian women. The lifetime risk of an Australian woman developing breast cancer
is one in eleven.
                                                     
1 Based on data for the years 1993 to 2001.
5There are still challenges for BreastScreen Australia to redevelop and target recruitment
strategies to better meet the needs of women and encourage them to participate in the
Program. In addition, to achieve the desired level of participation, the Program needs to
provide more flexible access to services, in particular to meet the needs of the cohort of baby
boomers, who are aging into the target age group and are more likely to be in the paid
workforce and might therefore have difficultly accessing BreastScreen Australia services.
Maintenance of high standards and development of the workforce and service capacity to
achieve the target participation rate of 70% with the increase in the eligible population will
also be important challenges for the Program in the next five years. The Program does,
however, have a strong base to build on and a structure and ethos that supports continuous
quality improvement. The results of the Program to date and the input and efforts of all
those working in the Program attest to that.
Key features of BreastScreen Australia
• A doctors referral is not required.
• Services are free to eligible women.
• Services are located throughout each Australian state and territory, using fixed or mobile
services to ensure that the Program is accessible to all women.
• Recruitment and reminder systems aim to ensure that women in the target group are
screened and rescreened in accordance with Program policy. The target group for
screening is women aged 5069 years, but women aged 4049 years and over 70 years
are also eligible to attend.
• Comprehensive, multi-disciplinary follow-up assessment services ensure that all women
with a screen-detected breast abnormality have appropriate specialist clinical assessment
to the point of diagnosis and referral to treatment services.
• A comprehensive system of accreditation ensures that all BreastScreen Australia services
operate under a common set of standards. Each service is regularly assessed by an
independent multi-disciplinary team to ensure that the service provided complies with
national standards.
Aims and Objectives of the BreastScreen Australia Program
Aims
• To ensure that the Program is implemented in such a way that significant reductions can
be achieved in morbidity and mortality attributable to breast cancer.
• To maximise the early detection of breast cancer in the target population.
• To ensure that screening for breast cancer in Australia is provided in dedicated
accredited screening and assessment services as part of the BreastScreen Australia
Program.
• To ensure equitable access to the Program for women aged 50-69 years.
6• To ensure that services are acceptable and appropriate to the needs of the eligible
population.
• To achieve high standards of program management, service delivery, monitoring and
evaluation, and accountability.
Objectives
• To achieve a 70% participation rate in the BreastScreen Australia Program by women in
the target age group and access to the Program for women aged 4049 years and 70 years
and over.
• To rescreen all women in the Program at two-yearly intervals.
• To achieve agreed performance outcomes that minimise recall rates, retake films,
invasive procedures, false negatives, and false positives, and to maximise the number
of cancers detected, particularly the number of small cancers.
• To refer to appropriate treatment services and collect information about the outcome of
treatment.
• To fund through State Coordination Units Screening and Assessment Services that are
accredited according to agreed National Accreditation Standards and to ensure that
those Standards are monitored and reviewed by appropriate State and Territory
Accreditation Committees.
• To recognise the real costs to women of participation in the Program and to minimise
those costs. This includes the provision of services at minimal or no charge and free to
eligible women who would not attend if there was a charge.
• To make information about mammographic screening and the BreastScreen Australia
Program available in easily comprehensible and appropriate forms in a variety of forums
and to women and health-care providers in particular.
• To achieve patterns of participation in the Program that are representative of the
socioeconomic, ethnic and cultural profiles of the target population.
• To provide services in accessible, non-threatening and comfortable environments, using
staff with appropriate expertise, experience and training.
• To provide appropriate service, in that the provision of counselling, education and
information is an integral part of the Program; sensitive procedures for notification of
recall are in place; and the time between the initial screen and assessment is minimised.
• To achieve high levels of participation in the development and management of the
Program by members of significant professional and client groups.
• To collect and analyse data sufficient to monitor the implementation of the Program, to
evaluate its effectiveness and efficiency, and to provide the basis for future policy and
program development decisions.
7Indicator 1: Participation
Participation rate
The participation rate is the percentage of women in the population screened through the
BreastScreen Australia Program in a 24-month period by 5-year age groups (4044, 4549,
5054, 5559, 6064, 6569, 7074, 7579, 8084, 85+ years) and for the target age group
(5069 years).
The participation indicator
The participation rate is a population-based indicator that measures the proportion of the
eligible population attending the screening program within the recommended screening
interval. All women who are Australian citizens and those with permanent residency status
are eligible for breast screening. It is important that a high proportion of women in the target
age group to attend for screening if BreastScreen Australia is to realise the anticipated
reductions in overall mortality from breast cancer (DHSH 1994). The participation rate is a
direct measure of this attendance. The indicator also provides information to assist in
assessing the effectiveness of the programs communication and education strategies, and
can be used to assess whether the target age group is well represented in the screening
population.
The focus of this report is on women who have had a mammogram in the BreastScreen
Australia Program. However, other mammography for screening and diagnosis (that is,
investigating breast symptoms) is conducted outside the program. To some extent, therefore,
the results presented in this report are an underestimation of screening on a national basis.
This chapter reports on the participation rates for the BreastScreen Australia Program for
2000 and 2001.
One of the objectives of the BreastScreen Australia Program is To achieve, after five years, a
70 per cent participation in the National Program by women in the target group (5069)
(BSANAC & DHAC 2000). The age-standardised national participation rate for women in
the target group in 20002001 was 56.9%. This rate has been steadily increasing since
19961997, when it was 52.3%.
Age-standardised participation rates for women in the target age group (5069 years), Australia,
19961997 to 20002001
Objective(a) 19961997 19971998 19981999 19992000 20002001
Rate (%) 70.0 52.3 54.3 55.6 55.9 56.9
95% CI . . 52.152.3 54.154.4 55.555.8 55.856.0 56.857.0
(a) Performance objective of the BreastScreen Australia Program as set out in the National Accreditation Standards (NQMC unpublished).
. . Not applicable.
Note: Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
Source: AIHW analysis of BreastScreen Australia data.
8Another BreastScreen Australia objective relating to participation is To achieve patterns of
participation in the Program which are representative of the socioeconomic, ethnic and
cultural profiles of the target population (BSANAC & DHAC 2000). This chapter reports
national participation rates by region, socioeconomic status, Indigenous status, and main
language spoken at home.
Participation rates in capital cities and Other remote areas were significantly lower than
those in other regions. The lower participation rates in capital cities may reflect greater
access to private radiology services. Or there may be a group of women in the target age
group who are working women and cannot easily access BreastScreen Australia services. For
some women, proximity to services could create over-familiarity and lead to postponement
of screening in order to accommodate other priorities. Lower rates in remote areas may
reflect a larger proportion of Indigenous women in the target age group who may not find
services culturally accessible. However, there are no data to test these hypotheses. Although
the participation rate for Other remote areas is lower than that for all other regions except
capital cities, it is similar to the all-Australia rate. Participation in country areas is
encouraged through the use of mobile mammography units.
There was some variation in the participation rates among different socioeconomic groups,
but there was only a marginally significant difference between the most and the least
disadvantaged groups. This demonstrates the success of the program in reaching women at
all socioeconomic levels, since there is no decline in participation with decreasing
socioeconomic status.
Participation among Indigenous women was significantly lower than that of non-
Indigenous women. Similarly, participation among women who speak a language other
than English at home was significantly lower than that of women who speak English at
home. These results should, however, be treated with caution because of the data issues
discussed in the report.
9Participation of women aged 5069 years in BreastScreen Australia,
20002001
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 56.9 53.0* 59.2* 58.4* 55.4* 64.3* 60.0* 57.0 46.3*
95% CI 56.857.0 52.953.2 59.059.4 58.158.6 55.155.7 63.964.7 59.360.6 56.057.8 45.147.5
* Significantly different from the all-Australia rate.
Notes
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
2. Period covers 1 January 2000 to 31 December 2001.
• In 20002001, 1,567,544 women were screened as part of the BreastScreen Australia
Program. Of these women, 1,063,479 (68%) were in the target age group (5069 years).
• In 20002001, 56.9% (age-standardised) of women in the target age group attended a
BreastScreen Australia service. The corresponding participation rate for all women aged
40 and over was 37.5% (Table 2).
• Across states and serritories, the age-standardised participation rate for women in the
target age group ranged from 46.3% in the Northern Territory to 64.3% in South
Australia.
For more information, see:
Tables 1 and 2
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Participation of women aged 5069 years in BreastScreen Australia,
19992000 and 20002001
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
19992000 55.9 52.5 57.7 57.6 52.7 63.5 59.7 59.1 47.6
95% CI 55.856.0 52.352.7 57.457.9 57.357.8 52.353.0 63.163.9 59.060.4 58.260.0 46.348.9
20002001 56.9* 53.0* 59.2* 58.4 55.4* 64.3 60.0 57.0* 46.3
95% CI 56.857.0 52.953.2 59.059.4 58.158.6 55.155.7 63.964.7 59.360.6 56.057.8 45.147.5
* Significantly different from the 19992000 rate.
Notes
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
2. Periods cover 1 January 1999 to 31 December 2000 and 1 January 2000 to 31 December 2001.
• Nationally, participation in BreastScreen Australia among women in the target age
group rose significantly from 19992000 to 20002001. The national age-standardised
participation rate for women in the target age group rose from 55.9% in 19992000 to
56.9% in 20002001.
• New South Wales, Victoria, Western Australia and the Australian Capital Territory were
the only jurisdictions to show a significant change in their age-standardised participation
rates for women in the target age group in 20002001. In Victoria, the rate rose from
57.7% in 19992000 to 59.2% in 20002001 and in Western Australia it rose from 52.7% to
55.4%. In the Australian Capital Territory the participation rate fell from 59.1% to 57.0%.
For more information, see:
Tables 1 and 2
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Participation of women aged 5069 years in BreastScreen Australia
by region, 20002001
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia
Capital
cities Other metro
Large rural
centres
Small rural
centres
Other rural
areas
Remote
centres
Other
remote
Rate (%) 56.9 54.8* 62.1* 63.3* 59.3* 59.6* 57.9 55.8*
95% CI 56.857.0 54.654.9 61.762.5 62.863.7 58.959.7 59.359.9 56.659.2 54.856.7
* Significantly different from the all-Australia rate.
Notes
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
2. Period covers 1 January 2000 to 31 December 2001.
• The age-standardised participation rate for women in the target age group (5069 years)
ranged from 54.8% in Capital cities to 63.3% in Large rural centres.
• In all regional categories except Capital cities, Remote centres and Other remote, the
age-standardised participation rates for women in the target age group were
significantly higher than the national rate. The rate of 54.8% recorded for Capital cities
was significantly lower than the national rate of 56.9%.
For more information, see:
Table 3
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Participation of women aged 5069 years in BreastScreen Australia
by socioeconomic status, 20002001
Notes:
1. Bars on columns represent 95% confidence intervals.
2. SES means socioeconomic status.
Source: AIHW analysis of BreastScreen Australia data.
Australia 1st quintile 2nd quintile 3rd quintile 4th quintile 5th quintile
Rate (%) 56.9 55.3* 59.4* 56.7 57.5* 55.9*
95% CI 56.857.0 55.155.6 59.259.7 56.456.9 57.357.8 55.756.1
* Significantly different from the all-Australia rate.
Notes
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
2. Period covers 1 January 2000 to 31 December 2001.
3. The first quintile corresponds to the highest socioeconomic status and the fifth to the lowest.
• Women in the target age group with the highest socioeconomic status had the lowest
age-standardised participation rate (55.3%) in 20002001. The socioeconomic group with
the highest age-standardised participation rate for women in the target age group was
the second quintile (59.4%).
• For women in the target age group, the most disadvantaged group (fifth quintile) had a
significantly higher participation rate (55.9%) than the least disadvantaged group (first
quintile), at 55.3%. Both groups participation rates were significantly lower than the
national rate (56.9%).
For more information, see:
Table 4
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Participation of women aged 5069 years in BreastScreen Australia
by Indigenous status, 20002001
Australia Indigenous Non-indigenous
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia Indigenous Non-Indigenous
Rate (%) 56.9 36.2* 56.9
95% CI 56.857.0 35.337.0 56.857.0
* Significantly different from the all-Australia rate.
Notes
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
2. Period covers 1 January 2000 to 31 December 2001.
3. Women whose Indigenous status was recorded as not stated were included in the analysis for all women but excluded from the analysis by
Indigenous status.
• Of the 1,567,544 women participating in screening through the BreastScreen Australia
Program in 20002001, there were 10,960 (0.7%) who identified themselves as
Indigenous. While 4,844 women were classified as not stating their Indigenous status,
the true figure is higher because some jurisdictions classified these women as non-
Indigenous (Appendix A). The comparison of participation rates between Indigenous
and non-Indigenous women should therefore be treated with caution.
• At 36.2%, the age-standardised participation rate for Indigenous women in the target age
group was significantly lower than both the national participation rate and the non-
Indigenous participation rate. The age-standardised participation rate for non-
Indigenous women was the same as the national participation rate (56.9%).
For more information, see:
Table 5
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Participation of women aged 5069 years in BreastScreen Australia
by language spoken at home, 20002001
Australia English speaking Non-English speaking
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia English speaking Non-English speaking
Rate (%) 56.9 58.5* 48.9*
95% CI 56.857.0 58.458.6 48.649.1
* Significantly different from the all-Australia rate.
Notes
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
2. Period covers 1 January 2000 to 31 December 2001.
3. Women who were recorded as not stating their language spoken at home are included in the analysis for all women but excluded from the
analysis by language.
• Of the 1,567,544 women participating in screening through the BreastScreen Australia
Program in 20002001, there were 212,844 (14%) who identified as non-English speaking.
While 1,417 women were classified as not stating the language they spoke at home, the
true figure may be higher as some jurisdictions did not use the not stated category.
Women in these jurisdictions who did not state the language they spoke at home were
allocated to one of the other two categories (Appendix A). Participation rates between
English speaking and non-English speaking women should therefore be treated with
caution.
• There was a significantly lower age-standardised rate of participation for women in the
target age group from a non-English speaking background (48.9%) than for English
speaking women (58.5%). English speaking women had a significantly higher
participation rate, at 58.6%, than the national rate of 56.9% (age-standardised).
For more information, see:
Table 6
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Age-distribution of women aged 40 years and over in BreastScreen
Australia, 20002001
Source: AIHW analysis of BreastScreen Australia data.
Age 4049 5069 70+
% 18.5 67.8 13.7
Notes
1. Rates are the number of women screened as a percentage of all women aged 40 or over screened by BreastScreen Australia.
2. Period covers 1 January 2000 to 31 December 2001.
• The majority of women participating in the BreastScreen Australia Program in 20002001
were in the target age group (5069 years). Of all women screened, 67.8% were aged
5069 years, 18.5% were aged 4049 years, and 13.7% were aged 70 years and over.
For more information, see:
Tables 1 and 2
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Indicator 2: Detection of small
invasive cancers
Small invasive cancer detection rate
The detection rate for small invasive cancers is the rate of women with small diameter
(≤ 15mm) invasive breast cancers per 10,000 women screened by five-year age groups
(4044, 4549, 5054, 5559, 6064, 6569, 7074, 7579, 8084, 85+ years) and for the target
age group (5069 years). Detection rates for all invasive cancers are also provided by
screening round (that is, first round and subsequent rounds), five-year age groups and for
the target age group.
The small invasive cancer detection indicator
The small invasive cancer detection indicator measures the rate of invasive breast cancers
that are 15 mm of less in size diagnosed in women attending BreastScreen Australia for
screening. This is expressed as the number of small cancers detected for every 10,000 women
screened.
A greater rate of detection of small cancers within the BreastScreen Australia Program
increases the likelihood that the anticipated reductions in morbidity and mortality from
breast cancer will be achieved. One of BreastScreen Australias aims is to maximise the early
detection of breast cancers (BSANAC & DHAC 2000). Finding breast cancer early often
means that the cancer is small, can be more effectively treated, and is less likely to have
spread to other parts of the body. As a result, women who have cancers detected early may
suffer less morbidity from breast cancer (Day 1991).
In 2001, 65% of all invasive breast cancers detected by BreastScreen Australia in women
aged 40 and over were small diameter cancers.
The table below shows the percentage of all invasive cancers detected that were small
diameter invasive breast cancers, by screening round, for women screened in 2001.
Percentage of invasive cancers detected that were small (≤ 15 mm) in diameter, 2001
First screening round Subsequent screening rounds
5069 years 58.2 66.3
Ages 40 and over 56.4 66.6
Source: AIHW analysis of BreastScreen Australia data.
It is evident that a higher proportion of women attending the program for the first time have
tumours larger than 15 mm compared with those who have been screened previously. This
is because regular, biennial mammography provides the best chance for the detection of
early-stage small cancers (AHMAC 1990).
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Small (≤ 15mm) invasive breast cancer detection in women aged
5069, first screening round, 2001
Aust NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate 38.4 39.3 35.5 42.5 29.6 35.5 97.8 57.9 . .
95% CI 33.743.2 31.247.0 27.044.2 31.154.4 14.847.2 15.162.5 39.7167.5 4.8118.2 . .
. . Not applicableno small invasive breast cancers were found in the Northern Territory at first-round screening in 2001.
Notes
1. Rates are the number of small invasive cancers detected per 10,000 women screened and age-standardised to the population of women
attending a BreastScreen Australia service in 1998.
2. None of the rates were significantly different from the all-Australia rate.
• Nationally, small diameter invasive cancers were found in 455 women aged 40 and over
in the first round of screening. Of these women, 285 were in the target age group (5069
years). The age-standardised detection rates were 38.4 per 10,000 women screened for
women in the target age group and 39.3 per 10,000 women screened for all women aged
40 and over (see Tables 7 and 8).
• Across the states and territories, the age-standardised detection rate for small invasive
cancers in women in the target age group ranged from none detected in the Northern
Territory to 97.8 per 10,000 women screened in Tasmania. Large confidence intervals can
be observed in the smaller states and territories due to the small number of cases
detected in these states and territories (see Table 7).
For more information, see:
Tables 7 and 8
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Small (≤ 15mm) invasive breast cancer detection in women aged
5069, subsequent screening rounds, 2001
Aust NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate 27.6 26.4 25.6 28.7 30.2 30.4 29.9 34.4 35.1
95% CI 26.129.0 23.728.9 22.828.6 25.532.0 25.135.2 25.635.3 20.139.9 22.348.1 11.366.9
Notes
1. Rates are the number of small invasive cancers detected per 10,000 women screened and age-standardised to the population of women
attending a BreastScreen Australia service in 1998.
2. None of the rates were significantly different from the all-Australia rate.
• For women in the target age group attending a BreastScreen Australia service for their
second or subsequent screen in 2001, small (≤ 15 mm diameter) invasive cancers were
detected at a rate of 27.6 per 10,000 women screened (age-standardised). The rate for all
women aged 40 and over was not significantly different at 25.8 per 10,000 women
screened. In both age categories, the small cancer detection rates for women attending
their second or subsequent screen were significantly lower than the rates for women
attending their first screen (Tables 8 and 10).
• The age-standardised detection rate of small invasive cancers by state and territory
ranged from 25.6 per 10,000 women screened in Victoria to 35.1 in the Northern
Territory. This difference was not statistically significant. Large confidence intervals can
be observed in the smaller states and territories due to the small number of cases
detected in these states and territories (see Table 9).
For more information, see:
Tables 9 and 10
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Small (≤ 15mm) invasive breast cancer detection in women aged
5069, all screening rounds, 2000 and 2001
Aust NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
2000 rate 29.6 25.0* 31.3 32.5 30.0 33.7 28.5 43.4 20.5
95% CI 28.131.1 22.627.5 28.534.1 29.136.0 25.134.8 28.638.8 20.137.1 29.658.5 3.343.4
2001 rate 29.0 28.5 27.0 30.5 29.7 30.5 33.9 36.1 28.9
95% CI 27.730.4 26.030.9 24.329.7 27.133.9 25.034.3 26.035.3 24.143.7 23.850.2 8.353.5
* Significantly different from the all-Australia rate for the same period.
Notes:
1. Rates are the number of small invasive cancers detected per 10,000 women screened and age-standardised to the population of women
attending a BreastScreen Australia service in 1998.
2. None of the 2001 rates were significantly different from the 2000 rates.
• Nationally, the age-standardised rate of small (≤ 15 mm diameter) invasive cancer
detection was 29 per 10,000 women screened in 2001. This was not significantly different
from the 2000 rate of 29.6 per 10,000 women screened. Large confidence intervals can be
observed in some states and territories due to the small number of cases detected.
• In 2001, small invasive cancers were detected in 2,379 women. Of these women, 1,652
(69%) were in the target age group (Table 11). Of women in the target age group with a
screen detected cancer, 65% were women with small invasive cancers. The proportion of
women with small invasive cancers of all women aged 40 and over with a screen
detected cancer was also 65%.
For more information, see:
Tables 7, 8, 9, 10 and 11
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Small (≤ 15mm) invasive breast cancer detection by age, 2001
Source: AIHW analysis of BreastScreen Australia data.
Age-specific rate 4044 4549 5054 5559 6064 6569 70+
First screening round 13.7 16.1 28.1 36.5 51.2 43.7 84.0
Subsequent screening rounds 8.2 9.5 19.9 26.9 32.4 35.8 44.3
Note: Rates are the number of small invasive cancers detected per 10,000 women screened.
 The steady increase in the detection of small (≤ 15 mm diameter) invasive cancers with
age in 2001 reflects the greater incidence of breast cancer with age (Table 42). The
detection rate for women aged 4044 making a first round attendance at a BreastScreen
Australia service in 20002001 was 13.7 per 10,000 women screened. This rate increases
to 84 per 10,000 women screened for women aged 70 and over, apart from a small
fluctuation for women aged between 65 and 69. A similar pattern occurred for women
making a second or subsequent round attendance, although the rate of increase with age
was not as great.
For more information, see:
Tables 8, 10 and 42
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All-size invasive breast cancer detection in women aged 5069
years, first screening round, 2001
Aust NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate 67.3 62.5 70.7 71.6 48.2 86.9 134.8 87.6 8.8*
95% CI 61.273.2 52.073.0 58.983.0 55.586.7 30.368.8 50.7126.4 65.3215.6 22.5165.7 0.026.3
* Significantly different from the all-Australia rate.
Note: Rates are the number of invasive cancers detected per 10,000 women screened and age-standardised to the population of women attending
a BreastScreen Australia service in 1998.
• The age-standardised rate of detection of invasive cancers of all sizes for women
attending a BreastScreen Australia Service for the first time in 2001 was 67.3 per 10,000
women screened. Across the states and territories, the Northern Territory had the lowest
age-standardised detection rate, at 8.8 per 10,000 women screened, and Tasmania had
the highest rate, at 134.8 per 10,000 women screened.
• The detection rate for invasive cancers among all women aged 40 and over (69.9 per
10,000 women screened) was not significantly different from the rate for women in the
target age group (67.3 per 10,000 women screened).
For more information, see:
Tables 13 and 14
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All-size invasive breast cancer detection in women aged 5069
years, subsequent screening rounds, 2001
Aust NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate 41.6 39.9 37.6 44.6 45.9 45.7 42.3 50.9 56.1
95% CI 39.943.3 36.643.1 34.240.8 40.048.7 40.051.8 39.451.7 32.353.4 33.467.9 24.893.0
Notes
1. Rates are the number of invasive cancers detected per 10,000 women screened and age-standardised to the population of women attending
a BreastScreen Australia service in 1998.
2. None of the rates were significantly different from the all-Australia rate.
 The age-standardised rate of detection of invasive cancers of all sizes in women in the
target age group attending a BreastScreen Australia service in 2001 for their second or
subsequent visit was 41.6 per 10,000 women screened. This is significantly lower than
the detection rate for first round attendances (67.3 per 10,000 women screened).
 The age-standardised rate of detection of invasive cancers for all women aged 40 and
over, attending for their second or subsequent screen was 39.0 per 10,000 women
screened. This is not significantly different from the rate for women in the target group
(41.6 per 10,000 women screened).
 Across the states and territories, age-standardised rate of detection of all invasive
cancers for women in the target age group ranged from 37.6 per 10,000 women screened
in Victoria to 56.1 per 10,000 women screened in the Northern Territory.
For more information, see:
Tables 15 and 16
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Indicator 3: Sensitivity
3a. Interval cancer rate
The interval cancer rate is the rate of invasive breast cancers detected during an interval
between two screening rounds per 10,000 women-years. It is stratified by 10-year age groups
(4049, 5059, 6069, 70+ years), time since screen (012 months, 1324 months, and 024
months) and screening round (first or subsequent).
3b. Program sensitivity
The program sensitivity rate is the percentage of women with screen-detected invasive
breast cancer among all women diagnosed with invasive breast cancer during the screening
interval (screen-detected and interval cancers). It is stratified by 10-year age groups (4049,
5059, 6069, 70+ years), time since screen (012 months, 024 months) and screening round
(first or subsequent).
The sensitivity indicator
An interval cancer is an invasive breast cancer that is diagnosed after a screening episode
that detected no cancer and before the next scheduled screening episode. The interval cancer
rate is expressed per 10,000 women-years (see the glossary for a definitions of women-
years and interval cancer). It measures how effective the BreastScreen Australia Program is
at detecting the presence of breast cancer in well women. A low interval cancer rate is one
measure of the effectiveness of the screening process.
Program sensitivity measures the ability of the Program to detect invasive breast cancers in
women attending for screening. The Program needs to achieve a high sensitivity in order to
be effective. Program sensitivity is the proportion of invasive breast cancers that are detected
within the BreastScreen Australia Program out of all invasive breast cancers (interval cancers
plus screen-detected cancers) diagnosed in program-screened women in the screening
interval.
In this chapter data for the years 1997, 1998 and 1999 are combined. This aggregation
improves the stability of rates, especially those of the small states and territories.
Data for the Northern Territory were unavailable at the time this report was compiled. Data
for New South Wales were incomplete for 1999, and so could not be included for 1324
months or 024 months follow-up.
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Interval cancer rate for women aged 5069 years, screened during
years 1997, 1998 and 1999, first screening round, 012 months
follow-up
Australia NSW Vic Qld WA SA Tas ACT NT
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Per 10,000 women-years
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate n.a. 7.7 8.0 6.4 6.0 8.6 9.4 1.9 n.a.
95% CI n.a. 6.09.4 5.510.3 4.68.1 3.09.7 5.012.4 2.319.0 0.05.8 n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. Northern Territory data were unavailable at the time of publication.
• Across the states and territories, the age-standardised rates of interval cancer for women
in the target age group (5069 years) 012 months after their first screen ranged from 1.9
per 10,000 women-years in the Australian Capital Territory to 9.4 per 10,000 women-
years in Tasmania.
For more information, see:
Table 17
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Interval cancer rate for women aged 5069 years, screened during
years 1997, 1998 and 1999, first screening round, 024 months
follow-up
Australia NSW Vic Qld WA SA Tas ACT NT
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Per 10,000 women-years
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate n.a. n.a. 11.2 11.2 9.3 9.8 14.5 11.0 n.a.
95% CI n.a. n.a. 9.213.1 9.612.9 6.512.2 7.112.5 7.322.1 3.619.8 n.a.
n.a. Not available
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. New South Wales and Northern Territory data were unavailable at the time of publication.
• Across the states and territories, the age-standardised rates of interval cancer for women
in the target age group 024 months after their first screen ranged from 9.3 per 10,000
women-years in Western Australia to 14.5 per 10,000 women-years in Tasmania.
For more information, see:
Table 19
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Interval cancer rate for women aged 5069 years, screened during
years 1997, 1998 and 1999, subsequent screening round,
012 months follow-up
Australia NSW Vic Qld WA SA Tas ACT NT
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Per 10,000 women-years
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate n.a. 8.0 6.8 7.1 7.7 8.4 9.5 10.3 n.a.
95% CI n.a. 7.18.9 5.87.7 5.88.4 5.99.3 6.710.2 6.212.8 6.015.1 n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. Northern Territory data were unavailable at the time of publication.
 Across the states and territories, the age-standardised rates of interval cancer for women
in the target age group 012 months after their subsequent screen ranged from 6.8 per
10,000 women-years in Victoria to 10.3 per 10,000 women-years in the Australia Capital
Territory.
For more information, see:
Table 20
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Interval cancer rate for women aged 5069 years, screened during
years 1997, 1998 and 1999, subsequent screening round,
024 months follow-up
Australia NSW Vic Qld WA SA Tas ACT NT
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Per 10,000 women-years
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate n.a. n.a. 10.1 11.3 9.3 10.2 10.3 11.3 n.a.
95% CI n.a. n.a. 9.311.0 10.112.4 8.010.6 8.811.5 7.712.9 7.814.6 n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. New South Wales and Northern Territory data were unavailable at the time of publication.
 Across the states and territories, the age-standardised rates of interval cancer for women
in the target age group 024 months after their subsequent screen ranged from 9.3 per
10,000 women-years in Western Australia to 11.3 per 10,000 women-years in
Queensland and the Australian Capital Territory.
For more information, see:
Table 22
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Program sensitivity for women aged 5069 years, screened during
years 1997, 1998 and 1999, first screening round, 012 months
follow-up
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) n.a. 87.5 89.0 89.7 89.2 87.3 86.1 96.6 n.a.
95% CI n.a. 85.189.9 86.291.9 87.192.3 83.694.4 82.491.9 75.097.2 89.7100.0 n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. Northern Territory data were unavailable at the time of publication.
• Across the states and territories, the Program sensitivity rate for women in the target age
group 012 months after their first screen ranged from 86.1% in Tasmania to 96.6% in the
Australian Capital Territory.
For more information, see:
Table 23
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Program sensitivity for women aged 5069 years, screened during
years 1997, 1998 and 1999, first screening round, 024 months
follow-up
Australia NSW Vic Qld WA SA Tas ACT NT
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Per cent
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) n.a. n.a. 74.5 74.4 81.3 76.5 68.2 79.7 n.a.
95% CI n.a. n.a. 71.177.8 71.177.9 74.687.4 70.881.9 55.281.1 65.091.7 n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. New South Wales and Northern Territory data were unavailable at the time of publication.
• Across the states and territories, the Program sensitivity rate for women in the target age
group 024 months after their first screen ranged from 68.2% in Tasmania to 81.3% in
Western Australia.
For more information, see:
Table 24
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Program sensitivity for women aged 5069 years, screened during
years 1997, 1998 and 1999, subsequent screening round,
012 months follow-up
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) n.a. 81.1 84.4 82.6 84.1 82.6 78.3 80.2 n.a.
95% CI n.a. 79.183.1 82.386.3 79.785.4 80.987.0 79.485.8 71.585.1 68.884.7 n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. Northern Territory data were unavailable at the time of publication.
• Across the states and territories, the Program sensitivity rate for women in the target age
group 012 months after their subsequent screen ranged from 78.3% in Tasmania to
84.4% in Victoria.
For more information, see:
Table 25
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Program sensitivity for women aged 5069 years, screened during
years 1997, 1998 and 1999, subsequent screening round,
024 months follow-up
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) n.a. n.a. 64.8 64.6 81.1 66.6 63.7 79.3 n.a.
95% CI n.a. n.a. 62.567.2 61.667.7 77.784.2 63.070.2 56.670.8 71.186.6 n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. The data include both symptomatic and asymptomatic women.
3. New South Wales and Northern Territory data were unavailable at the time of publication.
• Across the states and territories, the Program sensitivity rate for women in the target age
group (5069 years) 024 months after their subsequent screen ranged from 63.7% in
Tasmania to 81.1% in Queensland.
For more information, see:
Table 26
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Indicator 4: Ductal carcinoma in situ
Ductal carcinoma in situ detection rate
The ductal carcinoma in situ detection rate is the rate of women with ductal carcinoma in
situ per 10,000 women screened by 10-year age groups (4049, 5059, 6069, 70+ years) and
for the target age group (5069 years).
The DCIS detection indicator
The ductal carcinoma in situ (DCIS) indicator measures the rate of DCIS diagnosed in
women attending a BreastScreen Australia service. This is expressed as the number of cases
of DCIS detected for every 10,000 women screened. DCIS is a disease that involves changes
in the cells in the lining of the ducts of the breast. Although the changes are like those seen
in breast cancer, DCIS has not spread beyond the ducts (NBCC et al. 2000). The natural
history of DCIS is still not well understood, although women with the condition are at
increased risk of subsequent development of invasive breast cancer (NQMC unpublished).
DCIS is asymptomatic in the majority of cases and is usually detected as a change on a
mammogram or as a chance finding on a breast biopsy for another condition. Before the
introduction of nationwide mammographic screening in Australia in 1991, DCIS was rarely
found. Since then screening mammography has increased the detection rate for DCIS (NBCC
et al. 2000).
Early detection of high grade DCIS through screening, and its subsequent treatment, is likely
to prevent deaths from breast cancer (NQMC unpublished). The ability to detect DCIS can
also be seen as an indicator of the quality of the screening process, since it reflects
good-quality imaging and screen-film reading.
In 2001, the national age-standardised rate of DCIS detection was 10.4 cases per 10,000
women aged 40 and over. This is slightly lower than the detection rate for 2000, at 10.5 per
10,000 women screened, but the difference is not statistically significant.
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Ductal carcinoma in situ detection in women aged 5069 years,
2001
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate 11.2 10.1 12.5 9.8 15.2 10.8 8.7 15.2 . .
95% CI 10.312.1 8.711.5 10.814.4 7.911.8 11.818.6 8.013.6 4.213.9 7.323.9 . .
. . Not applicableno cases of DCIS were found in the Northern Territory in 2001.
Notes
1. Rates are the number of cases of DCIS per 10,000 women screened and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. None of the rates was significantly different from the all-Australia rate.
• In 2001, 883 cases of DCIS were detected in women participating in the BreastScreen
Australia Program, including 635 cases in women in the target age group. The age-
standardised DCIS detection rate was 11.2 per 10,000 women screened for women in the
target age group, and 10.4 per 10,000 women screened for all women aged 40 and over.
• The age-standardised rate of DCIS detection for women in the target age group ranged
from none detected in the Northern Territory to 15.2 per 10,000 women screened in
Western Australia and the Australian Capital Territory.
For more information, see:
Tables 27 and 28
34
Indicator 5: Recall to assessment
Recall to assessment rate
The recall to assessment rate is the proportion of all women screened in the calendar year
2001 who were recalled for assessment by five-year age groups (4044, 4549, 5054, 5559,
6064, 6569, 7074, 7579, 8084, and 85+ years) and for the target age group (5069 years).
The recall to assessment indicator
The recall to assessment indicator measures the rate of women that are recalled for
assessment following attendance for a routine screening at a BreastScreen Australia service.
The recall is made because a womans screening mammogram shows signs that there may
be breast cancer. During assessment, a woman might undergo further tests, such as
additional mammography, physical examination, ultrasound and, if required, a fine needle
aspiration or a core biopsy.
BreastScreen Australia aims to maximise the number of cancers detectedin particular, the
number of small cancerswhile minimising the number of unnecessary investigations. Most
women recalled to assessment are found not to have breast cancer (BreastScreen SA 1999;
BreastScreen Queensland 2000).
Women attending the program for the first time have a higher all-size cancer detection rate
than those who have previously been screened. This is reflected in a higher recall to
assessment rate for women who attend for their first screening round compared with those
who attend for a subsequent round. The table below shows recall to assessment rates by
screening round for 2000 and 2001.
Age-standardised recall to assessment rates for women aged 40 and over, 2000 and 2001
First screening round Subsequent screening rounds
2000 rate (%) 8.1 4.1
95% CI 8.08.3 4.04.2
2001 rate (%) 8.3 4.0
95% CI 8.18.5 4.04.1
Source: AIHW analysis of BreastScreen Australia data.
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Recall to assessment rate for women aged 5069 years, first
screening round, 2001
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 8.5 7.6* 8.7 9.7* 10.5* 5.3* 11.1* 10.4 4.2*
95% CI 8.28.7 7.27.9 8.49.1 9.210.2 9.711.3 4.46.1 9.212.9 8.212.9 2.26.3
* Significantly different from the all-Australia rate.
Note: Rates are the number of women recalled for assessment as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
• Of women in the target age group screened for the first time in 2001, 8.5% (age-
standardised) were recalled for assessment due to an abnormal mammogram result. The
age-standardised rate for all women aged 40 and over was 8.3%.
• Age-standardised rates of recall for assessment for women in the target age group
ranged from 4.2% in the Northern Territory to 11.1% in Tasmania. New South Wales, at
7.6%, South Australia, at 5.3%, and the Northern Territory, at 4.2%, all had recall rates
significantly lower than the national rate. Significantly higher than the national rate were
the Western Australian and Tasmanian rates, at 10.5% and 11.1% respectively.
For more information, see:
Tables 29 and 30
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Recall to assessment rate for women aged 5069 years,
subsequent screening round, 2001
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 3.9 3.7* 4.0 4.8* 3.8 2.3* 5.4* 5.1* 1.9*
95% CI 3.94.0 3.63.8 3.94.1 4.75.0 3.64.0 2.22.5 5.05.8 4.65.6 1.42.5
* Significantly different from the all-Australia rate.
Note: Rates are the number of women recalled for assessment as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
• Of women in the target age group who were screened for a second or subsequent time in
2001, 3.9% (age-standardised) were recalled for assessment due to an abnormal
mammogram result. The age-standardised recall rate for all women aged 40 and over
was 4.0%.
• Age-standardised rates of recall for assessment for women in the target age group
screened for a second or subsequent time ranged from 1.9% in the Northern Territory to
5.4% in Tasmania.
For more information, see:
Tables 31 and 32.
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Indicator 6: Rescreening
Rescreen rate
The rescreen rate is the proportion of all women screened in 1999 whose screening outcome
was a recommendation to return for screening in two years who returned for a screen within
27 months. This rate is reported by five-year age groups (4044, 4549, 5054, 5559, 6064,
6569, 7074, 7579, 8084, and 85+ years) and for the target age group (5069 years).
The rescreen indicator
The rescreen indicator measures the proportion of women who return for screening in the
program within the recommended screening interval. The interval between screens is an
important factor influencing the level of detection of cancers within the program. Intervals
that are too long may allow tumours to grow to the point where symptoms become evident,
thus eliminating the advantage of screening. A high rescreen rate is also important for
maintaining the participation rate. The anticipated reductions in mortality can only be
achieved only if a high proportion of women in the target age group attend for screening
every two years. By having a mammogram every two years, a woman can reduce her chance
of dying from breast cancer by up to 40% (Duffy et al. 1991; Fletcher et al. 1993; Feig 1998).
Women in the target age group are re-invited biennially. Some states and territories have a
policy of re-inviting a proportion of women annuallyfor example, women with a strong
family history of breast cancer. The data for this indicator include women who are
recommended for annual screening as well as those screened biennially.
The proportion of women who returned for screening within the recommended screening
interval increased with the number of screens a woman had previously attended. As can be
seen in the table below, the rescreen rate is greater for women who have attended for two
previous screens than for women who have been screened only once before, and greater still
for women who have previously attended three or more screening episodes.
One of the objectives of the BreastScreen Australia Program is To rescreen all women in the
Program at two-yearly intervals (BSANAC & DHAC 2000).
Age-standardised rescreen rates for women aged 40 years and over, screened during 1999, Australia
First screening round Second screening round
Subsequent screening
rounds
Rate (%) 64.7 75.0 82.5
95% CI 64.465.0 74.775.3 82.282.7
Source: AIHW analysis of BreastScreen Australia data.
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Rescreen rate for women aged 5069 years, screened during 1999,
first screening round
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 68.5 62.3* 70.2* 78.2* 57.3* 63.6* 70.3 45.5* 44.7*
95% CI 68.068.8 61.862.7 69.471.0 77.678.8 55.758.8 62.464.9 68.072.5 42.348.7 40.349.0
* Significantly different from the all-Australia rate.
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
• The age-standardised national rescreen rate for women in the target age group returning
for screening within 27 months of attending a BreastScreen Australia service in 1999 for
the first time was 68.5%. Of all women aged 40 and over, 64.7% returned for screening.
• Across the states and territories, the age-standardised rescreen rates for women in the
target age group ranged from 44.7% in the Northern Territory to 78.2% in Queensland.
Victoria and Queensland had rates significantly higher than the national rate.
For more information, see:
Tables 33 and 34
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Rescreen rate for women aged 5069 years, screened during 1999,
second screening round
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 77.7 72.7* 79.6* 86.4* 71.3* 73.8* 76.2 54.6* 65.0*
95% CI 77.378.2 72.473.1 79.180.1 86.086.9 70.572.1 72.874.8 74.478.0 51.657.2 62.467.7
* Significantly different from the all-Australia rate.
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
• The age-standardised national rescreen rate for women in the target age group returning
for screening within 27 months of attending a BreastScreen Australia service in 1999 for
the second time was 77.7%. For all women aged 40 and over, the rescreen rate was 75.0%.
• Across the states and territories, the age-standardised rescreen rates for the target age
group ranged from 54.6% in the Australian Capital Territory to 86.4% in Queensland.
Victoria and Queensland had rates significantly higher than the national rate.
For more information, see:
Tables 35 and 36
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Rescreen rate for women aged 5069 years, screened during 1999,
third and subsequent screening rounds
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW analysis of BreastScreen Australia data.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 85.2 82.4* 87.5* 91.1* 82.0* 83.7* 85.5 69.3* 77.3*
95% CI 84.985.5 82.282.7 87.287.7 90.991.4 81.582.4 83.384.1 84.886.2 68.170.5 74.580.1
* Significantly different from the all-Australia rate.
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
• The age-standardised national rescreen rate for women in the target age group returning
for screening within 27 months of attending a BreastScreen Australia service in 1999 for
their third or subsequent visit was 85.2%. Of all women aged 40 and over, 82.5%
returned for screening within 27 months.
• Across the states and territories, the age-standardised rescreen rates for the target age
group ranged from 69.3% in the Australian Capital Territory to 91.1% in Queensland.
For more information, see:
Tables 37 and 38
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Indicator 7: Incidence
7a. Incidence of breast cancer
The incidence rate of breast cancer is calculated per 100,000 estimated resident female
population in a 12-month period by five-year age groups ((04, 59, 1014, 1519, 2024, 25
29, 3034, 3539, 4044, 4549, 5054, 5559, 6064, 6569, 7074, 7579, 8084, 85+ years) and
for the target age group (5069 years).
7b. Incidence of ductal carcinoma in situ
The incidence rate of ductal carcinoma in situ (DCIS) is calculated per 100,000 estimated
resident female population in a six-year period by ten-year age groups (019, 2029, 3039,
4049, 5059, 6069, 70+ years), and for the target age group (5069 years).
The incidence indicator
Registration of cancer cases is required by law in each of the states and territories. The data
are collected by state and territory cancer registries and compiled in a national database, the
National Cancer Statistics Clearing House, which is held by the Australian Institute of
Health and Welfare. The data include clinical and demographic information about people
with newly diagnosed cancer. The incidence indicator measures the number of new cases of
breast cancer in the community each year. It does not distinguish between screen-detected
cancers and other detection methods.
Incidence data provide information about the underlying risk of breast cancer in the
Australian community. This knowledge can be used to assist in developing policies on
breast cancer screening. For example, examining the trends in breast cancer incidence in
different age groups helps to identify the ages at which women are most at risk of
developing breast cancer. Incidence data can also be used to set data performance standards
for breast cancer detection.
This chapter reports the rates of breast cancer from 1987 to 2000, the latest national data
available. This chapter also reports on breast cancer incidence by state and territory, and by
geographical region.
Similarly, data on the incidence of ductal carcinoma in situ (DCIS) provide information
about the underlying risk to Australian women of developing the condition. Data are
required to build more knowledge about DCIS, which was rarely detected before screening
was introduced. Since the introduction of screening mammography, the detection of DCIS
has increased (NBCC et al. 2000). More information is given on DCIS in the chapter headed
Indicator 4.
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Incidence of breast cancer in women, Australia, 19872000
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
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Source: AIHW National Cancer Statistics Clearing House.
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
All ages 91.2 89.7 93.5 94.6 100.4 98.0 105.3 113.9 115.7 109.2 111.2 114.9 111.2 115.4
<50 38.3 36.7 37.3 38.0 38.8 39.7 40.4 41.3 41.7 40.1 39.4 40.4 39.2 40.6
5069 197.1 194.8 208.5 209.6 230.5 221.6 250.6 281.6 285.3 269.7 276.5 290.1 287.5 296.2
70+ 279.1 279.7 287.1 292.0 304.0 290.1 301.8 322.3 331.1 305.8 318.7 321.9 296.1 312.1
 Note: Rates are the number of breast cancers detected per 100,000 women and age-standardised to the Australian population at 30 June 2001.
• With some fluctuation, a notable increase over the period 1987 to 2000 can be seen in the
age-standardised breast cancer incidence rates for women in the target age group.
Incidence has increased in this group from 197.1 new cancers per 100,000 women in 1987
to 296.2 per 100,000 women in 2000. A similar pattern of increase in incidence rates is
apparent in the 70 and over age group. Incidence rates have remained more consistent
over time in the all ages category and in women under 50 years of age.
• The increase in the rate of new cancers, especially in the target age group, corresponds
with the introduction in 1991 of BreastScreen Australia (then known as the National
Program for the Early Detection of Breast Cancer). Although the underlying rate for
breast cancer is increasing, the sharp increase between 1992 and 1994 is likely to be, at
least partly, the result of the early detection of cancers in women who may otherwise
have gone undiagnosed for some years.
For more information, see:
Tables 39 and 40
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Incidence of breast cancer in women, aged 5069 years, 19972000
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.
Source: AIHW National Cancer Statistics Clearing House.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate 287.8 282.5 285.7 293.2 285.8 308.3* 274.2 336.3* 220.9*
95% CI 283.7291.7 275.7289.6 278.0293.5 284.0303.3 272.7298.6 294.1323.1 250.6298.1 298.6370.2 173.0267.9
* Significantly different from the all-Australia rate.
 Note: Rates are the number of breast cancers detected per 100,000 women and age-standardised to the Australian population at 30 June 2001.
• The national age-standardised incidence rate for 1997 to 2000 was 287.8 new cancers per
100,000 women. Across the states and territories, incidence rates ranged from 220.9 new
cancers per 100,000 women in the Northern Territory to 336.3 new cases per 100,000
women in the Australian Capital Territory.
For more information, see:
Tables 41 and 42
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Agespecific incidence rates for breast cancer in women,
Australia 2000
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Source: AIHW National Cancer Statistics Clearing House.
Age 4044 4549 5054 5559 6064 6569 7074 7579 8084 85+
Rate 115.2 188.2 250.7 302.7 337.4 324.0 329.7 309.7 298.4 291.7
 Note: Rates are the number of breast cancers detected per 100,000 women.
• All women aged 40 and over are able to attend for screening with BreastScreen
Australia, although the Program is specifically aimed at women aged 5069 years of age
who are without symptoms. Of the 11,316 new cases of breast cancer in 2000, 5,452 (48%)
occurred in women in the target age group. Only 6% of cases were women aged under
40 years.
• Age-specific incidence rates in 2000, ranged from 115.2 new cancers per 100,000 women
in the 4044 age group to 337.4 new cases per 100,000 women in the 6064 age group.
For more information, see:
Tables 39 and 40
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Incidence of breast cancer in women by region, 19962000
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Source: AIHW National Cancer Statistics Clearing House.
Australia Capital cities
Other
metropolitan
areas
Large rural
centres
Small rural
centres
Other rural
areas
Remote
areas
All ages 112.3 115.2* 108.4 109.4 104.2* 108.9 95.5*
95% CI 111.3113.2 114.0116.4 105.2112.0 105.5113.3 100.8107.7 106.4111.5 88.7101.9
Ages 5069 284.0 292.5* 273.0 271.8 267.2* 275.1 222.0*
95% CI 280.2287.7 288.0296.9 260.8285.4 257.0286.0 253.9279.6 265.7284.6 201.3244.2
* Significantly different from the all-Australian rate.
 Note: Rates are the number of breast cancers detected per 100,000 women and age-standardised to the Australian population at 30 June 2001.
• For the period 1996 to 2000, the age-standardised incidence rate was 284.0 cases of breast
cancer per 100,000 women for women in the target age group, and 112.3 cases per
100,000 women for all women aged 40 and over. Breast cancer incidence rates for women
in the target age group ranged from 222.0 cases per 100,000 women in remote areas to
292.5 cases per 100,000 women in capital cities.
For more information, see:
Tables 43 and 44
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Incidence of ductal carcinoma in situ in women, aged 5069 years,
19952000
Note: Bars on columns represent 95% confidence intervals.
Source: National Cancer Statistics Clearing House.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate n.a. 32.6 n.a. 32.2 n.a. 41.1 39.3 34.8 25.6
95% CI n.a. 30.834.6 n.a. 29.534.8 n.a. 36.645.3 31.546.6 25.544.7 12.840.2
n.a. Not available.
Notes
1. Rates are the number of breast cancers detected per 100,000 women and age-standardised to the Australian population at 30 June 2001.
2. Data for Victoria and Western Australia were unavailable at the time of publication.
• Between 1995 and 2000, the age-standardised incidence of ductal carcinoma in situ for
women aged 5069 years ranged from 25.6 cases per 100,000 in the Northern Territory to
41.1 per 100,000 in South Australia.
For more information, see:
Tables 45 and 46
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Indicator 8: Mortality
Mortality rate
The mortality rate from breast cancer is calculated per 100,000 estimated resident female
population in a 12-month period by 5-year age groups (04, 59, 1014, 1519, 2024, 2529,
3034, 3539, 4044, 4549, 5054, 5559, 6064, 6569, 7074, 7579, 8084, 85+years) and for
the target age group (5069 years).
The mortality indicator
Mortality statistics are one of the most comprehensively collected national data sets.
Registration of death is a legal requirement in Australia and, as a result, compliance is
virtually complete. Registration of deaths is the responsibility of the Registrar of Births,
Deaths and Marriages in each state and territory. The Registrars provide the mortality data
to the Australian Bureau of Statistics for coding the cause of death and compilation into
national statistics. The Australian Institute of Health and Welfare also holds these data in a
national mortality database. The data presented here are from the AIHW National Mortality
Database and are based on year of registration of the death. Note that about 5% of deaths are
not registered until the year following the death (ABS 2002).
Breast cancer is the most common cause of cancer death in Australian women. The number
of deaths from breast cancer over the last five years has remained fairly stable, with 2,569
women dying from the disease in 1996 and 2,585 women in 2001. However, over this period
the rates of deaths caused by breast cancer have steadily fallen.
In the longer term, mortality rates from breast cancer are an important indicator of the
effectiveness of the screening program. A particularly important indication of the
effectiveness of a screening program is the change in mortality rates over time in the target
age group for screening. There are, however, two difficulties with using these mortality rates
as an indicator of screening effectiveness. The first is that changes in mortality over time
may reflect factors additional to screening, such as new and more effective treatments. The
second is that changes in the mortality rates may not be apparent for a number of years
following the commencement of a screening program. Accordingly, this is a measure that
needs to be viewed over the long term and interpreted with caution.
The mortality rates presented in this chapter are for the total female population of Australia,
not just for those women who participated in the BreastScreen Australia Program.
This chapter shows the trend in breast cancer mortality from 1988 to 2001, the latest national
data available. It also reports on breast cancer mortality by state and territory, by age, by
region, and by Indigenous status.
Some changes have been made to the coding and processing of mortality data. These are
described in Appendix A.
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Mortality from breast cancer, females, Australia, 19872001
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Source: AIHW National Mortality Database.
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
All
ages 30.0 30.5 30.8 30.4 30.5 28.9 30.5 30.0 28.9 28.1 27.8 26.5 25.4 24.7 24.7
<50 7.4 7.3 7.9 7.5 7.8 7.6 7.1 7.1 6.5 6.9 7.2 6.6 6.4 5.9 5.7
5069 66.8 68.3 66.7 68.5 66.5 60.6 67.9 65.5 64.6 61.5 60.6 57.3 55.0 52.5 51.8
70+ 128.3 131.2 134.1 127.9 130.9 127.4 133.9 131.3 128.0 122.9 119.7 117.3 111.4 112.7 115.9
Note: Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001.
• From 1993 a steady decline is evident in the age-standardised mortality rates for women
in the target age group. The mortality rate for these women was 66.8 deaths per 100,000
women in 1988; in 2001 the corresponding figure was 51.8 deaths per 100,000 women. A
similar pattern of decline in mortality rates can be observed in women aged 70 and over.
Mortality rates for women aged under 50 years remained the lowest and most consistent,
staying below 8 deaths per 100,000 women for the period 1987 to 2001.
For more information, see:
Tables 47 and 48
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Mortality from breast cancer in women aged 5069, 19982001
Note: Bars on columns represent 95% confidence intervals.
Source: AIHW National Mortality Database.
Australia NSW Vic Qld WA SA Tas ACT NT
Rate 54.1 52.5 56.6 52.8 49.9 55.1 56.8 73.9 71.0
95% CI 52.355.7 49.855.3 53.159.9 48.956.5 44.755.5 49.460.8 45.966.8 56.791.6 44.496.9
Notes
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001.
2. None of the rates was significantly different from the all-Australia rate.
• For the period 19982001, the national age-standardised mortality rate was 54.1 deaths
per 100,000 women. Across the states and territories, the mortality rate ranged from
49.9 deaths per 100,000 women in Western Australia to 73.9 deaths per 100,000 women in
the Australian Capital Territory.
For more information, see:
Tables 49 and 50
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Agespecific mortality rates for breast cancer, females, Australia,
2001
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Age 4044 4549 5054 5559 6064 6569 7074 7579 8084 85+
Rate 16.9 27.1 40.4 51.0 55.9 69.8 94.1 99.0 135.3 177.3
Note: Rates are the number of deaths from breast cancer per 100,000 women.
• In 2001, age-specific mortality rates increased consistently with age. For women aged
4044 , the rate was 16.9 deaths per 100,000 women. The rate increased to 177.3 deaths
per 100,000 women for women aged 85 and over.
• The pattern of breast cancer mortality by age group has remained the same over the
period 19882001.
For more information, see:
Tables 47 and 48
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Mortality from breast cancer by region, females, 19972001
Australia Capital
cities
Other metro
areas
Large rural
centres
Small rural
centres
Other
rural
Remote
areas
0
10
20
30
40
50
60
70
80
Deaths per 100,000 women
All ages
Ages 5069
Source: AIHW National Mortality Database.
Australia Capital cities
Other
metropolitan
areas
Large rural
centres
Small rural
centres
Other rural
areas
Remote
areas
All ages 25.8 26.1 24.2 26.1 24.1 26.3 23.2
95% CI 25.326.2 25.626.7 22.725.8 24.328.0 22.525.8 25.127.6 20.126.2
Ages 5069 55.3 56.6 50.3 55.8 48.5 57.5 46.1
95% CI 53.756.8 54.658.5 45.355.2 49.362.4 43.153.7 53.461.7 36.855.8
Notes
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001.
2. The Rural, Remote and Metropolitan Areas classification (DPIE & DHSH 1994) was used to create the above categories.
3. None of the rates was significantly different from the all-Australia rate.
• Across all regions, mortality rates were significantly higher for women in the target age
group than for the all ages group. For women in the target age group, mortality rates
ranged from 46.1 deaths per 100,000 women in Remote areas to 57.5 deaths per 100,000
women in Other rural areas. However, this difference was not significant.
For more information, see:
Tables 51 and 52
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Mortality from breast cancer by Indigenous status, females,
19972001
Australia Indigenous Non-Indigenous
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Australia Indigenous Non-Indigenous
All ages 25.9 21.0 27.8*
95% CI 25.526.4 13.928.3 27.028.6
Ages 5069 55.3 42.2 58.8
95% CI 53.856.8 24.763.5 56.361.7
* Significantly different from the all-Australian rate.
Notes
1. Only Queensland, Western Australia, South Australia and the Northern Territory had Indigenous death registration data considered to be of a
publishable standard at the time of preparation of this report. Therefore data from these jurisdictions only are included in the analysis by
Indigenous status. Data for Queensland are included from 1998 onwards.
2. Australia includes all states and territories.
3. Women whose Indigenous status was recorded as not stated are included in the analysis for all women but excluded from the analysis by
Indigenous status.
4. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001.
• In the target age group, the age-standardised mortality rate for Indigenous women
(42.2 deaths per 100,000 women) was lower than that for non-Indigenous women
(58.8 deaths per 100,000 women). However, this difference was not significant. In the all
ages category non-Indigenous women had a mortality rate significantly higher than the
national rate.
For more information, see:
Tables 53 and 54
53
Tables
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Indicator 1: Participation
Table 1: Number of women participating in breast screening in BreastScreen Australia by age,
states and territories, 20002001
Age
group NSW Vic Qld WA SA Tas ACT NT Australia
4044 44,585 11,013 32,966 7,485 6,833 2,880 1,667 837 108,266
4549 72,749 20,745 47,806 15,863 13,328 5,929 3,724 1,395 181,539
5054 104,217 90,071 66,818 32,432 33,310 9,257 6,223 2,486 344,814
5559 91,058 73,594 54,038 25,484 26,159 7,782 4,612 1,637 284,364
6064 77,753 62,082 43,544 21,775 22,567 6,694 3,289 932 238,636
6569 64,799 51,433 35,437 17,289 18,430 5,480 2,280 517 195,665
7074 52,490 41,524 26,734 4,891 6,936 1,747 576 315 135,213
7579 29,898 11,050 12,297 1,955 2,798 627 244 121 58,990
8084 9,411 1,702 3,868 449 668 134 66 54 16,352
85+ 2,121 374 938 104 112 34 17 5 3,705
Ages 40+ 549,081 363,588 324,446 127,727 131,141 40,564 22,698 8,299 1,567,544
Ages
5069 337,827 277,180 199,837 96,980 100,466 29,213 16,404 5,572 1,063,479
Note: Period covers 1 January 2000 to 31 December 2001.
Source: AIHW analysis of BreastScreen Australia data.
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Table 2: Percentage of women participating in BreastScreen Australia, states and territories,
20002001
Age
group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4044 18.0 6.0 24.1 10.1 11.8 15.7 13.1 11.4 14.7
4549 32.2 12.4 37.9 23.0 24.6 34.9 30.2 21.5 26.7
5054 49.3 57.1 56.1 52.3 63.6 57.7 53.8 46.9 54.2
5559 55.2 61.4 59.4 56.5 65.3 61.8 60.1 49.1 58.7
6064 56.0 61.0 60.2 58.5 66.6 61.9 60.2 46.5 59.3
6569 53.4 57.7 59.2 55.9 61.6 59.2 54.5 41.0 56.6
7074 44.3 47.8 47.1 17.3 22.7 19.9 15.4 35.6 40.5
7579 29.0 14.7 25.4 8.3 10.1 8.1 7.5 21.1 20.4
8084 13.4 3.4 11.7 2.8 3.6 2.5 3.2 13.8 8.3
85+ 3.4 0.8 3.2 0.7 0.6 0.7 1.0 1.7 2.1
Ages 40+
Crude
rate 37.5 33.7 42.0 31.8 36.2 36.6 35.1 29.8 36.6
ASR(A) 38.2 34.6 42.6 32.6 37.8 37.8 34.8 31.1 37.5
95% CI 38.138.3 34.534.7 42.442.7 32.432.8 37.638.0 37.338.1 34.335.3 30.431.8 37.437.5
Ages
5069
Crude
rate 53.1 59.1 58.4 55.3 64.3 60.0 56.8 46.8 56.9
ASR(A) 53.0 59.2 58.4 55.4 64.3 60.0 57.0 46.3 56.9
95% CI 52.953.2 59.059.4 58.158.6 55.155.7 63.964.7 59.360.6 56.057.8 45.147.5 56.857.0
Notes
1. Period covers 1 January 2000 to 31 December 2001.
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian
population at 30 June 2001.
Source: AIHW analysis of BreastScreen Australia data.
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Table 3: Participation in BreastScreen Australia by age and region, 20002001
Age group
Number/
Rate
Capital
cities
Other
metro-
politan
areas
Large rural
centres
Small rural
centres
Other rural
areas
Remote
centres
Other
remote
areas Australia
4044 Number 59,781 12,760 8,432 7,066 15,841 1,880 2,505 108,266
Rate 12.7 22.9 19.4 14.9 15.9 22.6 21.8 14.7
4549 Number 104,352 19,317 13,539 12,093 26,080 2,715 3,444 181,539
Rate 23.9 37.6 34.1 28.1 28.7 38.8 34.5 26.7
5054 Number 214,396 28,939 21,710 23,148 48,655 3,221 4,745 344,814
Rate 52.4 59.4 60.8 57.0 56.2 55.4 53.0 54.2
5559 Number 169,590 25,039 18,339 20,711 44,329 2,394 3,962 284,364
Rate 56.4 64.3 65.6 60.9 61.4 59.6 57.7 58.7
6064 Number 138,814 21,511 15,910 19,040 38,627 1,629 3,106 238,636
Rate 57.1 64.2 64.9 61.2 62.2 60.5 57.5 59.3
6569 Number 112,586 18,357 13,619 16,757 30,904 1,158 2,284 195,665
Rate 54.0 61.3 62.7 58.9 60.2 56.9 56.1 56.6
7074 Number 76,131 15,405 10,122 11,377 20,048 648 1,483 135,213
Rate 37.4 51.0 47.2 41.2 43.3 40.0 46.0 40.5
7579 Number 32,857 7,531 4,214 4,767 8,670 269 682 58,990
Rate 18.2 29.2 22.4 20.6 23.0 22.8 28.7 20.4
8084 Number 8,792 2,349 1,199 1,350 2,366 87 209 16,352
Rate 7.2 14.0 9.1 8.8 9.3 10.7 13.5 8.3
85+ Number 1,962 517 293 258 601 21 54 3,705
Rate 1.7 3.6 2.4 2.0 2.6 2.8 3.9 2.1
Ages 40+ Number 919,261 151,726 107,377 116,566 236,120 14,021 22,474 1,567,544
Crude rate 34.2 44.0 41.5 38.4 39.7 41.0 40.7 36.6
ASR(A) 35.2 44.6 43.1 38.9 39.6 41.5 40.6 37.5
95% CI 35.2-35.3 44.4-44.8 42.8-43.3 38.6-39.1 39.5-39.8 40.7-42.2 40.1-41.2 37.4-37.5
Ages 5069 Number 635,386 93,847 69,577 79,655 162,515 8,402 14,097 1,063,479
Crude rate 54.7 62.1 63.3 59.4 59.7 57.7 55.7 56.9
ASR(A) 54.8 62.1 63.3 59.3 59.6 57.9 55.8 56.9
95% CI 54.654.9 61.762.5 62.863.7 58.959.7 59.359.9 56.659.2 54.856.7 56.857.0
Notes
1. Period covers 1 January 2000 to 31 December 2001.
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
Source: AIHW analysis of BreastScreen Australia data.
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Table 4: Participation in BreastScreen Australia by age and socioeconomic status, 20002001
Age group Number/ Rate  1st quintile 2nd quintile 3rd quintile 4th quintile 5th quintile Australia
4044 Number 21,400 20,822 20,771 23,256 22,016 108,266
Rate 13.4 13.8 14.2 16.3 16.1 14.7
4549 Number 37,926 33,648 35,396 38,452 36,117 181,539
Rate 24.1 24.3 27.4 30.0 28.8 26.7
5054 Number 74,387 71,601 65,587 66,957 66,282 344,814
Rate 51.5 57.0 54.2 54.9 54.0 54.2
5559 Number 58,160 56,277 54,875 57,430 57,622 284,364
Rate 58.5 61.9 58.2 58.7 56.4 58.7
6064 Number 44,738 44,638 46,760 50,906 51,594 238,636
Rate 58.6 61.6 58.9 59.9 57.9 59.3
6569 Number 35,546 35,844 38,644 42,481 43,150 195,665
Rate 53.9 57.8 56.7 58.1 56.3 56.6
7074 Number 25,940 25,793 27,110 28,620 27,751 135,213
Rate 38.5 42.5 40.8 42.2 38.6 40.5
7579 Number 11,903 10,334 12,274 12,455 12,024 58,990
Rate 19.3 19.4 21.1 21.9 20.1 20.4
8084 Number 3,271 2,735 3,472 3,418 3,457 16,352
Rate 7.3 7.4 9.0 9.4 9.0 8.3
85+ Number 722 670 792 744 777 3,705
Rate 1.6 1.9 2.2 2.4 2.3 2.1
Ages 40+ Number 313,993 302,362 305,681 324,719 320,789 1,567,544
Crude rate 34.0 36.6 36.5 38.6 37.4 36.6
ASR(A) 35.8 38.1 37.5 38.8 37.4 37.5
95% CI 35.735.9 38.038.2 37.337.6 38.739.0 37.337.6 37.437.5
Ages 5069 Number 212,831 208,360 205,865 217,774 218,648 1,063,479
Crude rate 55.1 59.4 56.7 57.6 56.0 56.9
ASR(A) 55.3 59.4 56.7 57.5 55.9 56.9
95% CI 55.155.6 59.259.7 56.456.9 57.357.8 55.756.1 56.857.0
Notes
1. Period covers 1 January 2000 to 31 December 2001.
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
3. The first quintile corresponds to the highest level of socioeconomic status and the fifth to the lowest.
Source: AIHW analysis of BreastScreen Australia data.
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Table 5: Participation in BreastScreen Australia by age and Indigenous status, 20002001
Age group Number/Rate Indigenous Non-Indigenous Australia
4044 Number 1,473 106,677 108,266
Rate 11.8 14.7 14.7
4549 Number 1,960 179,189 181,539
Rate 19.9 26.8 26.7
5054 Number 2,487 341,017 344,814
Rate 33.4 54.3 54.2
5559 Number 1,875 281,618 284,364
Rate 37.7 58.7 58.7
6064 Number 1,419 236,468 238,636
Rate 37.3 59.3 59.3
6569 Number 1,014 193,971 195,665
Rate 37.8 56.5 56.6
7074 Number 520 134,258 135,213
Rate 28.3 40.4 40.5
75+ Number 212 78,542 79,047
Rate 9.4 11.9 11.9
Ages 40+ Number 10,960 1,551,740 1,567,544
Crude rate 24.2 36.6 36.6
ASR(A) 25.1 37.4 37.4
95% CI 24.625.6 37.337.5 37.337.4
Ages 5069 Number 6,795 1,053,074 1,063,479
Crude rate 35.9 56.9 56.9
ASR(A) 36.2 56.9 56.9
95% CI 35.337.0 56.857.0 56.857.0
Notes
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
2. Period covers 1 January 2000 to 31 December 2001.
3. Women in the unknown category are included in the column for all women, but are not included in the other columns.
Source: AIHW analysis of BreastScreen Australia data.
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Table 6: Participation in BreastScreen Australia by age and main language spoken at home,
20002001
Age group Number/Rate  English speaking
Non-English
speaking Australia
4044 Number 94,996 13,182 108,266
Rate 15.6 10.4 14.7
4549 Number 158,318 23,061 181,539
Rate 28.0 20.3 26.7
5054 Number 298,209 46,305 344,814
Rate 55.8 45.7 54.2
5559 Number 245,294 38,807 284,364
Rate 59.8 52.0 58.7
6064 Number 199,959 38,452 238,636
Rate 60.7 52.5 59.3
6569 Number 165,455 30,029 195,665
Rate 58.9 46.1 56.6
7074 Number 118,948 16,155 135,213
Rate 42.4 30.1 40.5
7579 Number 53,306 5,615 58,990
Rate 21.7 12.8 20.4
8084 Number 15,300 1,035 16,352
Rate 8.8 4.7 8.3
85+ Number 3,498 203 3,705
Rate 2.2 1.1 2.1
Ages 40+ Number 1,353,283 212,844 1,567,544
Crude rate 37.7 30.7 36.6
ASR(A) 38.8 30.6 37.5
95% CI 38.738.8 30.530.7 37.437.5
Ages 5069 Number 908,917 153,593 1,063,479
Crude rate 58.5 48.9 56.9
ASR(A) 58.5 48.9 56.9
95% CI 58.458.6 48.649.1 56.857.0
Notes
1. Period covers 1 January 2000 to 31 December 2001.
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian population
at 30 June 2001.
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 2: Detection rate for small invasive cancers
Table 7: Numbers of women screened and cases of small diameter (≤ 15 mm) invasive cancers
detected in women screened, first screening round, by age, states and territories, 2001
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 13,638 4,386 9,823 2,508 2,152 809 568 312 34,196
Cases 20 5 14 4 4 0 0 0 47
4549 Screened 10,801 5,218 6,328 2,957 2,272 659 612 290 29,137
Cases 16 10 10 6 5 0 0 0 47
5054 Screened 13,357 13,059 7,125 4,560 4,284 725 679 371 44,160
Cases 46 35 22 9 9 2 1 0 124
5559 Screened 5,851 4,533 3,360 1,227 848 280 200 135 16,434
Cases 22 16 14 3 2 2 1 0 60
6064 Screened 4,406 3,660 2,354 884 418 209 110 68 12,109
Cases 23 14 13 4 2 4 2 0 62
6569 Screened 3,136 2,976 1,653 573 325 139 72 40 8,914
Cases 11 14 8 2 2 2 0 0 39
7074 Screened 1,916 1,216 954 244 172 60 33 19 4,614
Cases 10 12 7 9 1 0 0 0 39
7579 Screened 1,335 553 598 180 167 72 24 12 2,941
Cases 10 6 8 0 1 1 0 0 26
8084 Screened 561 226 207 65 60 15 8 7 1,149
Cases 3 3 1 0 0 0 0 0 7
85+ Screened 146 79 62 26 23 7 3 0 346
Cases 0 2 2 0 0 0 0 0 4
Ages
40+ Screened 55,147 35,906 32,464 13,224 10,721 2,975 2,309 1,254 154,000
Cases 161 117 99 37 26 11 4 0 455
Ages
5069 Screened 26,750 24,228 14,492 7,244 5,875 1,353 1,061 614 81,617
Cases 102 79 57 18 15 10 4 0 285
Source: AIHW analysis of BreastScreen Australia data.
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Table 8: Age-specific rates of small diameter (≤ 15 mm) invasive cancers detected in women
screened, first screening round, states and territories, 2001
Age group NSW Vic Qld WA SA Tas ACT NT Australia
4044 14.7 11.4 14.3 15.9 18.6 0.0 0.0 0.0 13.7
4549 14.8 19.2 15.8 20.3 22.0 0.0 0.0 0.0 16.1
5054 34.4 26.8 30.9 19.7 21.0 27.6 14.7 0.0 28.1
5559 37.6 35.3 41.7 24.4 23.6 71.4 50.0 0.0 36.5
6064 52.2 38.3 55.2 45.2 47.8 191.4 181.8 0.0 51.2
6569 35.1 47.0 48.4 34.9 61.5 143.9 0.0 0.0 43.8
7074 52.2 98.7 73.4 368.9 58.1 0.0 0.0 0.0 84.5
7579 74.9 108.5 133.8 0.0 59.9 138.9 0.0 0.0 88.4
8084 53.5 132.7 48.3 0.0 0.0 0.0 0.0 0.0 60.9
85+ 0.0 253.2 322.6 0.0 0.0 0.0 0.0 0.0 115.6
Ages 40+
Crude rate 29.2 32.6 30.5 28.0 24.3 37.0 17.3 0.0 29.5
ASR(A) 36.4 40.2 42.8 54.4 34.7 69.6 38.7 0.0 39.3
95% CI 30.042.7 32.349.0 32.952.4 32.978.5 18.157.2 32.5119.7 3.279.0 . . 35.043.5
Ages 5069
Crude rate 38.1 32.6 39.3 24.8 25.5 73.9 37.7 0.0 34.9
ASR(A) 39.3 35.5 42.5 29.6 35.5 97.8 57.9 0.0 38.4
95% CI 31.247.0 27.044.2 31.154.4 14.847.2 15.162.5 39.7167.5 4.8118.2 . . 33.743.2
. . Not applicableno small invasive breast cancers were found in the Northern Territory at first-round screening in 2001.
Note: Rates are the number of small invasive cancers detected per 10,000 women screened and age-standardised to the population of women
attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Table 9: Numbers of women screened and cases of small diameter (≤ 15 mm) invasive cancers
detected in these women, subsequent screening rounds, by age, states and territories, 2001
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 9,575 1,043 7,415 1,576 1,306 579 320 140 21,954
Cases 6 1 10 0 0 0 1 0 18
4549 Screened 27,561 4,864 18,968 5,752 4,500 2,202 1,265 450 65,562
Cases 20 3 26 4 1 5 3 0 62
5054 Screened 42,464 33,227 27,508 13,286 12,810 3,753 2,582 850 136,480
Cases 70 69 56 37 26 9 3 2 272
5559 Screened 43,823 35,834 25,495 13,299 13,715 3,714 2,293 781 138,954
Cases 133 79 62 35 45 11 7 2 374
6064 Screened 38,082 28,664 20,734 11,420 12,002 3,279 1,728 478 116,387
Cases 110 86 75 35 49 13 8 1 377
6569 Screened 32,494 23,454 16,956 9,245 9,636 2,754 1,250 241 96,030
Cases 113 78 68 36 31 8 8 2 344
7074 Screened 26,913 19,791 13,529 2,470 3,436 1,095 266 137 67,637
Cases 106 69 58 9 18 12 2 0 274
7579 Screened 16,146 5,104 5,882 914 1,308 283 109 50 29,796
Cases 68 17 19 12 14 4 1 0 135
8084 Screened 5,261 648 1,915 198 301 61 34 26 8,444
Cases 30 6 11 4 2 0 0 0 53
85+ Screened 1,147 142 429 42 38 8 4 2 1,812
Cases 5 0 6 0 2 1 1 0 15
Ages
40+ Screened 243,466 152,771 138,831 58,202 59,052 17,728 9,851 3,155 683,056
Cases 661 408 391 172 188 63 34 7 1,924
Ages
5069 Screened 156,863 121,179 90,693 47,250 48,163 13,500 7,853 2,350 487,851
Cases 426 312 261 143 151 41 26 7 1,367
Source: AIHW analysis of BreastScreen Australia data.
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Table 10: Age-specific rates of small diameter (≤ 15 mm) invasive cancers detected in women
screened, subsequent screening rounds, states and territories, 2001
Age group NSW Vic Qld WA SA Tas ACT NT Australia
4044 6.3 9.6 13.5 0.0 0.0 0.0 31.3 0.0 8.2
4549 7.3 6.2 13.7 7.0 2.2 22.7 23.7 0.0 9.5
5054 16.5 20.8 20.4 27.8 20.3 24.0 11.6 23.5 19.9
5559 30.3 22.0 24.3 26.3 32.8 29.6 30.5 25.6 26.9
6064 28.9 30.0 36.2 30.6 40.8 39.6 46.3 20.9 32.4
6569 34.8 33.3 40.1 38.9 32.2 29.0 64.0 83.0 35.8
7074 39.4 34.9 42.9 36.4 52.4 109.6 75.2 0.0 40.5
7579 42.1 33.3 32.3 131.3 107.0 141.3 91.7 0.0 45.3
8084 57.0 92.6 57.4 202.0 66.4 0.0 0.0 0.0 62.8
85+ 43.6 0.0 139.9 0.0 526.3 1250.0 2500.0 0.0 82.8
Ages 40+
Crude rate 27.1 26.7 28.2 29.6 31.8 35.5 34.5 22.2 28.2
ASR(A) 24.2 23.4 27.3 29.9 29.8 38.7 42.3 23.4 25.8
95% CI 22.226.0 20.726.3 24.629.9 25.034.8 25.334.1 28.549.1 26.259.9 7.544.7 24.627.0
Ages 5069
Crude rate 27.2 25.7 28.8 30.3 31.4 30.4 33.1 29.8 28.0
ASR(A) 26.4 25.6 28.7 30.2 30.4 29.9 34.4 35.1 27.6
95% CI 23.728.9 22.828.6 25.532.0 25.135.2 25.635.3 20.139.9 22.348.1 11.366.9 26.129.0
Note: Rates are the number of small invasive cancers detected per 10,000 women screened and age-standardised to the population of women
attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Table 11: Numbers of women screened and cases of small diameter (≤ 15 mm) invasive cancers
detected in these women, all screening rounds, by age, states and territories, 2001
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 23,213 5,429 17,238 4,084 3,458 1,388 888 452 56,150
Cases 26 6 24 4 4 0 1 0 65
4549 Screened 38,362 10,082 25,296 8,709 6,772 2,861 1,877 740 94,699
Cases 36 13 36 10 6 5 3 0 109
5054 Screened 55,821 46,286 34,633 17,846 17,094 4,478 3,261 1,221 180,640
Cases 116 104 78 46 35 11 4 2 396
5559 Screened 49,674 40,367 28,855 14,526 14,563 3,994 2,493 916 155,388
Cases 155 95 76 38 47 13 8 2 434
6064 Screened 42,488 32,324 23,088 12,304 12,420 3,488 1,838 546 128,496
Cases 133 100 88 39 51 17 10 1 439
6569 Screened 35,630 26,430 18,609 9,818 9,961 2,893 1,322 281 104,944
Cases 124 92 76 38 33 10 8 2 383
7074 Screened 28,829 21,007 14,483 2,714 3,608 1,155 299 156 72,251
Cases 116 81 65 18 19 12 2 0 313
7579 Screened 17,481 5,657 6,480 1,094 1,475 355 133 62 32,737
Cases 78 23 27 12 15 5 1 0 161
8084 Screened 5,822 874 2,122 263 361 76 42 33 9,593
Cases 33 9 12 4 2 0 0 0 60
85+ Screened 1,293 221 491 68 61 15 7 2 2,158
Cases 5 2 8 0 2 1 1 0 19
Ages
40+ Screened 298,613 188,677 171,295 71,426 69,773 20,703 12,160 4,409 837,056
Cases 822 525 490 209 214 74 38 7 2,379
Ages
5069 Screened 183,613 145,407 105,185 54,494 54,038 14,853 8,914 2,964 569,468
Cases 528 391 318 161 166 51 30 7 1,652
Source: AIHW analysis of BreastScreen Australia data.
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Table 12: Age-specific rates of small diameter (≤ 15 mm) invasive cancers detected in women
screened, all screening rounds, states and territories, 2001
Age group NSW Vic Qld WA SA Tas ACT NT Australia
4044 11.2 11.1 13.9 9.8 11.6 0.0 11.3 0.0 11.6
4549 9.4 12.9 14.2 11.5 8.9 17.5 16.0 0.0 11.5
5054 20.8 22.5 22.5 25.8 20.5 24.6 12.3 16.4 21.9
5559 31.2 23.5 26.3 26.2 32.3 32.5 32.1 21.8 27.9
6064 31.3 30.9 38.1 31.7 41.1 48.7 54.4 18.3 34.2
6569 34.8 34.8 40.8 38.7 33.1 34.6 60.5 71.2 36.5
7074 40.2 38.6 44.9 66.3 52.7 103.9 66.9 0.0 43.3
7579 44.6 40.7 41.7 109.7 101.7 140.8 75.2 0.0 49.2
8084 56.7 103.0 56.6 152.1 55.4 0.0 0.0 0.0 62.5
85+ 38.7 90.5 162.9 0.0 327.9 666.7 1,428.6 0.0 88.0
Ages 40+
Crude rate 27.5 27.8 28.6 29.3 30.7 35.7 31.3 15.9 28.4
ASR(A) 26.4 26.1 29.1 32.3 31.1 39.1 37.6 19.3 27.6
95% CI 24.428.4 23.728.5 26.331.8 27.637.2 26.635.6 29.847.8 24.852.5 5.635.7 26.428.7
Ages 5069
Crude rate 28.8 26.9 30.2 29.5 30.7 34.3 33.7 23.6 29.0
ASR(A) 28.5 27.0 30.5 29.7 30.5 33.9 36.1 28.9 29.0
95% CI 26.030.9 24.329.7 27.133.9 25.034.3 26.035.3 24.143.7 23.850.2 8.353.5 27.730.4
Note: Rates are the number of small invasive cancers detected per 10,000 women screened and age-standardised to the population of women
attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Table 13: Numbers of women screened and cases of invasive cancer detected in these women, first
screening round, by age, states and territories, 2001
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 13,638 4,386 9,823 2,508 2,152 809 568 312 34,196
Cases 29 14 20 6 5 0 1 0 75
4549 Screened 10,801 5,218 6,328 2,957 2,272 659 612 290 29,137
Cases 36 22 24 8 8 1 2 0 101
5054 Screened 13,357 13,059 7,125 4,560 4,284 725 679 371 44,160
Cases 70 56 36 18 15 4 3 1 203
5559 Screened 5,851 4,533 3,360 1,227 848 280 200 135 16,434
Cases 30 37 23 6 8 2 1 0 107
6064 Screened 4,406 3,660 2,354 884 418 209 110 68 12,109
Cases 37 33 21 5 4 4 3 0 107
6569 Screened 3,136 2,976 1,653 573 325 139 72 40 8,914
Cases 22 24 15 3 5 4 0 0 73
7074 Screened 1,916 1,216 954 244 172 60 33 19 4,614
Cases 19 22 11 10 1 0 0 0 63
7579 Screened 1,335 553 598 180 167 72 24 12 2,941
Cases 24 15 14 2 2 1 0 0 58
8084 Screened 561 226 207 65 60 15 8 7 1,149
Cases 5 5 2 0 1 0 1 0 14
85+ Screened 146 79 62 26 23 7 3 0 346
Cases 2 2 2 0 0 0 0 0 6
Ages
40+ Screened 55,147 35,906 32,464 13,224 10,721 2,975 2,309 1,254 154,000
Cases 274 230 168 58 49 16 11 1 807
Ages
5069 Screened 26,750 24,228 14,492 7,244 5,875 1,353 1,061 614 81,617
Cases 159 150 95 32 32 14 7 1 490
Source: AIHW analysis of BreastScreen Australia data.
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Table 14: Age-specific rates of invasive breast cancers per 10,000 women screened, first screening
round, states and territories, 2001
Age group NSW Vic Qld WA SA Tas ACT NT Australia
4044 21.3 31.9 20.4 23.9 23.2 0.0 17.6 0.0 21.9
4549 33.3 42.2 37.9 27.1 35.2 15.2 32.7 0.0 34.7
5054 52.4 42.9 50.5 39.5 35.0 55.2 44.2 27.0 46.0
5559 51.3 81.6 68.5 48.9 94.3 71.4 50.0 0.0 65.1
6064 84.0 90.2 89.2 56.6 95.7 191.4 272.7 0.0 88.4
6569 70.2 80.6 90.7 52.4 153.8 287.8 0.0 0.0 81.9
7074 99.2 180.9 115.3 409.8 58.1 0.0 0.0 0.0 136.5
7579 179.8 271.2 234.1 111.1 119.8 138.9 0.0 0.0 197.2
8084 89.1 221.2 96.6 0.0 166.7 0.0 1,250.0 0.0 121.8
85+ 137.0 253.2 322.6 0.0 0.0 0.0 0.0 0.0 173.4
Ages 40+
Crude rate 49.7 64.1 51.7 43.9 45.7 53.9 47.6 8.0 52.4
ASR(A) 62.5 80.9 72.5 75.2 74.4 96.2 74.8 5.9 69.9
95% CI 53.971.3 70.192.6 59.785.5 51.6103.0 47.0104.3 48.2150.4 26.7131.8 0.017.6 64.875.3
Ages 5069
Crude rate 59.4 61.9 65.6 44.2 54.5 103.5 66.0 16.3 60.0
ASR(A) 62.5 70.7 71.6 48.2 86.9 134.8 87.6 8.8 67.3
95% CI 52.073.0 58.983.0 55.586.7 30.368.8 50.7126.4 65.3215.6 22.5165.7 0.026.3 61.273.2
Note: Rates are the number of invasive cancers detected per 10,000 women screened and age-standardised to the population of women attending
a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Table 15: Numbers of women screened and cases of invasive cancer detected in these women,
subsequent screening rounds, by age, states and territories, 2001
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 9,575 1,043 7,415 1,576 1,306 579 320 140 21,954
Cases 11 1 17 1 2 0 1 0 33
4549 Screened 27,561 4,864 18,968 5,752 4,500 2,202 1,265 450 65,562
Cases 41 8 41 8 11 7 3 1 120
5054 Screened 42,464 33,227 27,508 13,286 12,810 3,753 2,582 850 136,480
Cases 101 104 91 50 45 9 9 3 412
5559 Screened 43,823 35,834 25,495 13,299 13,715 3,714 2,293 781 138,954
Cases 201 113 104 60 61 18 8 3 568
6064 Screened 38,082 28,664 20,734 11,420 12,002 3,279 1,728 478 116,387
Cases 178 129 115 60 70 20 8 4 584
6569 Screened 32,494 23,454 16,956 9,245 9,636 2,754 1,250 241 96,030
Cases 166 112 96 49 49 12 13 2 499
7074 Screened 26,913 19,791 13,529 2,470 3,436 1,095 266 137 67,637
Cases 150 101 83 14 25 13 4 0 390
7579 Screened 16,146 5,104 5,882 914 1,308 283 109 50 29,796
Cases 86 37 27 15 21 5 2 0 193
8084 Screened 5,261 648 1,915 198 301 61 34 26 8,444
Cases 41 8 15 4 2 1 0 0 71
85+ Screened 1,147 142 429 42 38 8 4 2 1,812
Cases 6 1 6 0 2 1 1 0 17
Ages
40+ Screened 243,466 152,771 138,831 58,202 59,052 17,728 9,851 3,155 683,056
Cases 981 614 595 261 288 86 49 13 2,887
Ages
5069 Screened 156,863 121,179 90,693 47,250 48,163 13,500 7,853 2,350 487,851
Cases 646 458 406 219 225 59 38 12 2,063
Source: AIHW analysis of BreastScreen Australia data.
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Table 16: Age-specific rates of invasive breast cancers per 10,000 women screened, subsequent
screening rounds, by age, states and territories, 2001
Age group NSW Vic Qld WA SA Tas ACT NT Australia
4044 11.5 9.6 22.9 6.3 15.3 0.0 31.3 0.0 15.0
4549 14.9 16.4 21.6 13.9 24.4 31.8 23.7 22.2 18.3
5054 23.8 31.3 33.1 37.6 35.1 24.0 34.9 35.3 30.2
5559 45.9 31.5 40.8 45.1 44.5 48.5 34.9 38.4 40.9
6064 46.7 45.0 55.5 52.5 58.3 61.0 46.3 83.7 50.2
6569 51.1 47.8 56.6 53.0 50.9 43.6 104.0 83.0 52.0
7074 55.7 51.0 61.3 56.7 72.8 118.7 150.4 0.0 57.7
7579 53.3 72.5 45.9 164.1 160.6 176.7 183.5 0.0 64.8
8084 77.9 123.5 78.3 202.0 66.4 163.9 0.0 0.0 84.1
85+ 52.3 70.4 139.9 0.0 526.3 1250.0 2500.0 0.0 93.8
Ages 40+
Crude rate 40.3 40.2 42.9 44.8 48.8 48.5 49.7 41.2 42.3
ASR(A) 36.5 35.6 41.9 44.4 47.4 51.4 62.4 40.3 39.0
95% CI 34.138.8 32.438.9 38.345.2 38.950.2 41.553.1 40.063.7 42.884.7 18.365.6 37.640.5
Ages 5069
Crude rate 41.2 37.8 44.8 46.3 46.7 43.7 48.4 51.1 42.3
ASR(A) 39.9 37.6 44.6 45.9 45.7 42.3 50.9 56.1 41.6
95% CI 36.643.1 34.240.8 40.048.7 40.051.8 39.451.7 32.353.4 33.467.9 24.893.0 39.943.3
Note: Rates are the number of invasive cancers detected per 10,000 women screened and age-standardised to the population of women attending
a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 3a: Interval cancer rate
Table 17: Numbers and age-specific rates of interval cancers in women screened during 1997, 1998
and 1999, first screening round, 012 months, states and territories
Age group
Number/
Rate NSW Vic Qld WA SA Tas ACT NT Australia
4049 Number 65 23 27 13 9 3 2 n.a. n.a.
Rate 7.5 6.8 5.1 7.0 6.3 5.5 5.5 n.a. n.a.
5059 Number 62 44 36 10 22 2 1 n.a. n.a.
Rate 8.3 7.6 6.8 6.2 12.2 4.4 3.3 n.a. n.a.
6069 Number 26 12 17 4 2 3 0 n.a. n.a.
Rate 7.0 8.5 5.9 5.8 3.6 35.1 0.0 n.a. n.a.
70+ Number 20 9 4 1 0 0 0 n.a. n.a.
Rate 10.3 10.7 3.5 3.4 0.0 0.0 0.0 n.a. n.a.
Ages 40+ Number 173 88 84 28 33 8 3 n.a. n.a.
Crude rate 7.9 7.7 5.8 6.3 8.2 6.3 3.8 n.a. n.a.
ASR(A) 8.0 8.0 5.8 5.9 7.1 7.4 2.4 n.a. n.a.
95%CI 6.79.3 6.19.9 4.57.1 3.78.4 4.59.9 2.414.0 0.05.7 n.a. n.a.
Ages 5069 Number 88 56 53 14 24 5 1 n.a. n.a.
Crude rate 7.8 7.8 6.5 6.1 10.2 7.8 2.6 n.a. n.a.
ASR(A) 7.7 8.0 6.4 6.0 8.6 9.4 1.9 n.a. n.a.
95%CI 6.09.4 5.510.3 4.68.1 3.09.7 5.012.4 2.319.0 0.05.8 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. Northern Territory data were unavailable at the time of publication
Source: AIHW analysis of BreastScreen Australia data.
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Table 18: Numbers and age-specific rates of interval cancers in women screened during 1997, 1998
and 1999, first screening round, 1324 months, states and territories
Age group
Number/
Rate NSW Vic Qld WA SA Tas ACT NT Australia
4049 Number n.a. 45 57 12 22 5 1 n.a. n.a.
Rate n.a. 13.2 11.3 6.5 16.5 9.8 2.9 n.a. n.a.
5059 Number n.a. 76 86 16 24 4 5 n.a. n.a.
Rate n.a. 13.1 16.8 10.1 13.5 9.2 17.0 n.a. n.a.
6069 Number n.a. 23 43 11 4 6 2 n.a. n.a.
Rate n.a. 16.2 15.2 16.2 7.2 35.1 25.3 n.a. n.a.
70+ Number n.a. 9 16 6 1 0 1 n.a. n.a.
Rate n.a. 10.7 14.2 21.1 3.8 0.0 24.6 n.a. n.a.
Ages 40+ Number n.a. 153 202 45 51 15 9 n.a. n.a.
Crude rate n.a. 13.4 14.3 10.3 13.0 12.4 11.8 n.a. n.a.
ASR(A) n.a. 13.7 14.9 12.4 11.2 15.4 17.3 n.a. n.a.
95%CI n.a. 11.416.1 12.817.0 8.816.4 8.014.8 7.124.6 5.330.5 n.a. n.a.
Ages 5069 Number n.a. 99 129 27 28 10 7 n.a. n.a.
Crude rate n.a. 13.7 16.3 11.9 12.0 16.5 18.8 n.a. n.a.
ASR(A) n.a. 14.4 16.2 12.6 10.9 20.0 20.5 n.a. n.a.
95%CI n.a. 11.317.9 13.318.9 7.417.4 6.815.4 8.634.0 6.038.2 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Table 19: Numbers and age-specific rates of interval cancers in women screened during 1997, 1998
and 1999, first screening round, 024 months, states and territories
Age group
Number/
Rate NSW Vic Qld WA SA Tas ACT NT Australia
4049 Number n.a. 68 84 25 31 8 3 n.a. n.a.
Rate n.a. 10.0 8.2 6.7 11.3 7.6 4.2 n.a. n.a.
5059 Number n.a. 120 122 26 46 6 6 n.a. n.a.
Rate n.a. 10.4 11.7 8.2 12.9 6.7 10.0 n.a. n.a.
6069 Number n.a. 35 60 15 6 9 2 n.a. n.a.
Rate n.a. 12.3 10.6 11.0 5.4 25.5 12.4 n.a. n.a.
70+ Number n.a. 18 20 7 1 0 1 n.a. n.a.
Rate n.a. 10.7 8.8 12.2 1.9 0.0 12.2 n.a. n.a.
Ages 40+ Number n.a. 241 286 73 84 23 12 n.a. n.a.
Crude rate n.a. 10.5 10.0 8.3 10.5 9.3 7.8 n.a. n.a.
ASR(A) n.a. 10.9 10.3 9.1 9.1 11.3 9.8 n.a. n.a.
95%CI n.a. 9.312.4 9.111.6 6.811.4 7.111.1 6.416.6 4.217.0 n.a. n.a.
Ages 5069 Number n.a. 155 182 41 52 15 8 n.a. n.a.
Crude rate n.a. 10.8 11.3 9.0 11.1 12.0 10.5 n.a. n.a.
ASR(A) n.a. 11.2 11.2 9.3 9.8 14.5 11.0 n.a. n.a.
95%CI n.a. 9.213.1 9.612.9 6.512.2 7.112.5 7.322.1 3.619.8 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Table 20: Numbers and age-specific rates of interval cancers in women screened during 1997, 1998
and 1999, subsequent screening rounds, 012 months, states and territories
Age group
Number/
Rate NSW Vic Qld WA SA Tas ACT NT Australia
4049 Number 83 16 32 19 24 6 6 n.a. n.a.
Rate 9.2 8.8 5.6 10.0 16.5 6.6 11.0 n.a. n.a.
5059 Number 172 111 75 53 60 21 10 n.a. n.a.
Rate 8.3 6.9 7.8 8.6 10.0 11.1 8.1 n.a. n.a.
6069 Number 136 90 44 30 32 11 10 n.a. n.a.
Rate 7.7 6.6 6.2 6.4 6.1 7.3 13.5 n.a. n.a.
70+ Number 55 30 26 7 3 5 1 n.a. n.a.
Rate 5.4 5.0 6.4 9.9 3.0 22.4 8.5 n.a. n.a.
Ages 40+ Number 446 247 177 109 119 43 27 n.a. n.a.
Crude rate 7.7 6.6 6.7 8.1 8.7 9.5 10.2 n.a. n.a.
ASR(A) 7.9 7.0 6.7 8.4 9.4 10.5 10.2 n.a. n.a.
95%CI 7.28.7 5.98.1 5.77.7 6.710.2 7.611.2 7.214.0 6.214.3 n.a. n.a.
Ages 5069 Number 308 201 119 83 92 32 20 n.a. n.a.
Crude rate 8.0 6.8 7.1 7.6 8.2 9.4 10.1 n.a. n.a.
ASR(A) 8.0 6.8 7.1 7.7 8.4 9.5 10.3 n.a. n.a.
95%CI 7.18.9 5.87.7 5.88.4 5.99.3 6.710.2 6.212.8 6.015.1 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. Northern Territory data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Table 21: Numbers and age-specific rates of interval cancers in women screened during 1997, 1998
and 1999, subsequent screening rounds, 1324 months, states and territories
Age group
Number/
Rate NSW Vic Qld WA SA Tas ACT NT Australia
4049 Number n.a. 20 67 9 19 9 3 n.a. n.a.
Rate n.a. 11.1 12.7 5.9 14.9 10.9 6.2 n.a. n.a.
5059 Number n.a. 208 138 61 73 26 18 n.a. n.a.
Rate n.a. 13.0 15.1 11.5 12.4 14.5 15.9 n.a. n.a.
6069 Number n.a. 192 115 43 59 9 5 n.a. n.a.
Rate n.a. 14.2 16.5 10.9 11.5 6.3 7.3 n.a. n.a.
70+ Number n.a. 69 49 5 12 3 2 n.a. n.a.
Rate n.a. 11.6 12.1 8.7 12.4 14.4 17.4 n.a. n.a.
Ages 40+ Number n.a. 489 369 118 163 47 28 n.a. n.a.
Crude
rate n.a. 13.1 14.5 10.4 12.3 11.1 11.6 n.a. n.a.
ASR(A) n.a. 12.8 14.6 9.8 12.7 11.5 11.7 n.a. n.a.
95%CI n.a. 11.314.1 13.116.1 8.011.8 10.314.8 8.115.1 6.916.9 n.a. n.a.
Ages 5069 Number n.a. 400 253 104 132 35 23 n.a. n.a.
Crude
rate n.a. 13.5 15.7 11.3 12.0 10.9 12.7 n.a. n.a.
ASR(A) n.a. 13.5 15.7 11.3 12.1 11.1 12.3 n.a. n.a.
95%CI n.a. 12.214.8 13.817.7 9.213.5 9.914.2 7.614.9 7.117.6 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Table 22: Numbers and age-specific rates of interval cancers in women screened during 1997, 1998
and 1999, subsequent screening rounds, 024 months, states and territories
Age group
Number/
Rate NSW Vic Qld WA SA Tas ACT NT Australia
4049 Number n.a. 36 99 28 43 15 9 n.a. n.a.
Rate n.a. 10.0 9.0 8.2 15.8 8.7 8.7 n.a. n.a.
5059 Number n.a. 319 213 114 133 47 28 n.a. n.a.
Rate n.a. 10.0 11.3 9.9 11.2 12.8 11.8 n.a. n.a.
6069 Number n.a. 282 159 73 91 20 15 n.a. n.a.
Rate n.a. 10.4 11.4 8.4 8.8 6.8 10.5 n.a. n.a.
70+ Number n.a. 99 75 12 15 8 3 n.a. n.a.
Rate n.a. 8.3 9.2 9.4 7.6 18.5 12.9 n.a. n.a.
Ages 40+ Number n.a. 736 546 227 282 90 55 n.a. n.a.
Crude rate n.a. 9.9 10.5 9.1 10.5 10.3 10.9 n.a. n.a.
ASR(A) n.a. 9.9 10.6 9.1 11.0 11.0 11.0 n.a. n.a.
95%CI n.a. 8.910.7 9.711.5 7.910.3 9.612.4 8.513.5 7.914.0 n.a. n.a.
Ages 5069 Number n.a. 601 372 187 224 67 43 n.a. n.a.
Crude rate n.a. 10.2 11.3 9.3 10.1 10.1 11.3 n.a. n.a.
ASR(A) n.a. 10.1 11.3 9.3 10.2 10.3 11.3 n.a. n.a.
95%CI n.a. 9.311.0 10.112.4 8.010.6 8.811.5 7.712.9 7.814.6 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 3b: Program sensitivity
Table 23: Program sensitivity rates for women screened during 1997, 1998 and 1999, first screening
round, 012 months, states and territories
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4049 72.9 76.5 84.4 76.4 79.1 76.9 77.8 n.a. n.a.
5059 85.3 86.7 87.5 86.1 80.5 90.5 94.1 n.a. n.a.
6069 90.5 92.1 92.9 93.4 96.7 80.0 100.0 n.a. n.a.
70+ 92.3 93.6 97.8 97.4 100.0 100.0 100.0 n.a. n.a.
Ages 40+
Crude rate 85.5 87.8 90.5 87.6 87.2 86.9 92.7 n.a. n.a.
ASR(A) 85.1 87.0 89.6 87.5 87.1 85.9 93.1 n.a. n.a.
95% CI 83.087.1 84.389.6 87.591.9 83.091.7 83.091.1 76.994.4 86.2100.0 n.a. n.a.
Ages 50
69
Crude rate 87.4 88.4 89.9 89.5 86.2 86.1 96.4 n.a. n.a.
ASR(A) 87.5 89.0 89.7 89.2 87.3 86.1 96.6 n.a. n.a.
95% CI 85.189.9 86.291.9 87.192.3 83.694.4 82.491.9 75.097.2 89.7100.0 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Table 24: Program sensitivity rates for women screened during years 1997, 1998 and 1999, first
screening round, 024 months, states and territories
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4049 n.a. 52.4 67.0 77.8 52.3 55.6 87.5 n.a. n.a.
5059 n.a. 70.5 69.8 79.5 66.4 76.0 76.2 n.a. n.a.
6069 n.a. 80.0 81.0 83.8 90.8 57.1 84.6 n.a. n.a.
70+ n.a. 88.0 90.8 86.0 97.6 100.0 80.0 n.a. n.a.
Ages 40+
Crude rate n.a. 72.5 76.0 81.5 72.8 69.7 80.9 n.a. n.a.
ASR(A) n.a. 71.6 74.9 81.2 74.1 69.5 81.4 n.a. n.a.
95% CI n.a. 68.674.5 72.377.6 75.986.1 69.778.4 60.279.3 70.492.3 n.a. n.a.
Ages 5069
Crude rate n.a. 73.4 74.6 81.5 74.3 67.4 79.4 n.a. n.a.
ASR(A) n.a. 74.5 74.4 81.3 76.5 68.2 79.7 n.a. n.a.
95% CI n.a. 71.177.8 71.177.9 74.687.4 70.881.9 55.281.1 65.091.7 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Table 25: Program sensitivity rates for women screened during 1997, 1998 and 1999, subsequent
screening rounds, 012 months, states and territories
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4049 61.9 72.9 74.6 66.7 60.0 69.6 57.1 n.a. n.a.
5059 78.5 82.0 78.9 80.3 78.3 75.3 84.4 n.a. n.a.
6069 84.9 87.8 87.8 89.3 88.7 82.5 74.4 n.a. n.a.
70+ 90.5 92.3 90.7 89.4 95.6 75.0 90.0 n.a. n.a.
Ages 40+
Crude rate 82.1 86.3 84.2 83.8 82.7 77.0 78.7 n.a. n.a.
ASR(A) 78.3 83.0 82.0 81.1 79.5 76.1 76.6 n.a. n.a.
95% CI 76.480.2 80.285.7 79.684.4 77.784.5 76.083.0 69.682.5 59.487.7 n.a. n.a.
Ages 5069
Crude rate 81.9 85.1 83.4 84.9 83.5 78.4 80.6 n.a. n.a.
ASR(A) 81.1 84.4 82.6 84.1 82.6 78.3 80.2 n.a. n.a.
95% CI 79.183.1 82.386.3 79.785.4 80.987.0 79.485.8 71.585.1 68.884.7 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Table 26: Program sensitivity rates for women screened during 1997, 1998 and 1999, subsequent
screening rounds, 024 months, states and territories
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4049 n.a. 54.4 52.8 66.7 45.6 51.6 72.7 n.a. n.a.
5059 n.a. 61.3 61.3 80.3 61.9 57.7 75.0 n.a. n.a.
6069 n.a. 69.6 69.2 89.3 73.3 72.2 85.3 n.a. n.a.
70+ n.a. 78.4 80.7 89.4 81.3 65.2 81.8 n.a. n.a.
Ages 40+
Crude rate n.a. 67.9 67.2 82.7 66.8 62.0 78.1 n.a. n.a.
ASR(A) n.a. 64.3 64.2 82.4 64.1 61.4 78.2 n.a. n.a.
95% CI n.a. 61.567.1 61.666.8 79.185.5 60.567.7 55.267.5 69.785.8 n.a. n.a.
Ages 5069
Crude rate n.a. 65.7 65.3 81.8 67.5 63.4 78.3 n.a. n.a.
ASR(A) n.a. 64.8 64.6 81.1 66.6 63.7 79.3 n.a. n.a.
95% CI n.a. 62.567.2 61.667.7 77.784.2 63.070.2 56.670.8 71.186.6 n.a. n.a.
n.a. Not available.
Notes
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-standardised
to the population of women attending a BreastScreen Australia service in 1998.
2. Northern Territory and New South Wales data were unavailable at the time of publication.
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 4: Ductal carcinoma in-situ
Table 27: Number of women screened and cases of DCIS detected in these women by age, states
and territories, 2001
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
4049 Screened 61,579 15,511 42,535 12,794 10,230 4,249 2,765 1,192 150,855
Cases 41 12 16 13 14 3 4 0 103
5059 Screened 105,493 86,653 63,489 32,371 31,658 8,472 5,754 2,137 336,027
Cases 107 94 56 37 33 5 7 0 339
6069 Screened 78,119 58,754 41,696 22,124 22,380 6,381 3,160 827 233,441
Cases 78 87 47 45 25 8 6 0 296
70+ Screened 53,422 27,759 23,575 4,137 5,505 1,601 481 253 116,733
Cases 66 27 32 10 8 2 0 0 145
Ages 40+ Screened 298,613 188,677 171,295 71,426 69,773 20,703 12,160 4,409 837,056
Cases 292 220 151 105 80 18 17 0 883
Ages 5069 Screened 183,612 145,407 105,185 54,495 54,038 14,853 8,914 2,964 569,468
Cases 185 181 103 82 58 13 13 0 635
Source: AIHW analysis of BreastScreen Australia data.
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Table 28: Age-specific rate of DCIS detected in women screened, states and territories, 2001
Age
group NSW Vic Qld WA SA Tas ACT NT Australia
4049 6.7 7.7 3.8 10.2 13.7 7.1 14.5 0.0 6.8
5059 10.1 10.8 8.8 11.4 10.4 5.9 12.2 0.0 10.1
6069 10.0 14.8 11.3 20.3 11.2 12.5 19.0 0.0 12.7
70+ 12.4 9.7 13.6 24.2 14.5 12.5 0.0 0.0 12.4
Ages 40+
Crude rate 9.8 11.7 8.8 14.7 11.5 8.7 14.0 0.0 10.5
ASR(A) 9.7 11.1 9.0 15.1 11.9 8.6 13.1 0.0 10.4
95% CI 8.610.8 9.712.8 7.510.5 12.118.4 9.114.5 5.012.7 7.119.2 . . 9.711.1
Ages 50
69
Crude rate 10.1 12.4 9.8 15.0 10.7 8.8 14.6 0.0 11.2
ASR(A) 10.1 12.5 9.8 15.2 10.8 8.7 15.2 0.0 11.2
95% CI 8.711.5 10.814.4 7.911.8 11.818.6 8.013.6 4.213.9 7.323.9 . . 10.312.1
. . Not applicableno cases of DCIS were found in the Northern Territory in 2001.
Note: Rates are the number of cases of DCIS per 10,000 women screened and age-standardised to the population of women attending a
BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 5: Recall to assessment rate
Table 29: Numbers of women screened and women recalled for assessment by age, first screening
round, states and territories, 2001
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 13,646 4,386 9,824 2,508 2,152 809 568 312 34,205
Recalled 833 326 814 254 84 93 24 17 2,445
4549 Screened 10,807 5,218 6,329 2,959 2,272 659 612 290 29,146
Recalled 799 453 623 381 121 85 57 13 2,532
5054 Screened 13,360 13,059 7,126 4,560 4,285 725 679 371 44,165
Recalled 1,092 1,184 767 528 200 91 64 11 3,937
5559 Screened 5,855 4,533 3,362 1,227 848 280 200 135 16,440
Recalled 450 413 305 123 43 27 24 4 1,389
6064 Screened 4,407 3,660 2,355 884 418 209 110 68 12,111
Recalled 330 317 224 84 27 27 13 3 1,025
6569 Screened 3,144 2,977 1,654 573 325 139 72 40 8,924
Recalled 206 232 150 60 17 12 6 3 686
7074 Screened 1,917 1,216 955 244 172 60 33 19 4,616
Recalled 135 110 75 31 9 4 4 2 370
7579 Screened 1,335 553 598 180 167 72 24 12 2,941
Recalled 114 39 49 13 8 6 2 1 232
8084 Screened 561 226 207 65 60 15 8 7 1,149
Recalled 32 17 22 3 1 2 1 0 78
85+ Screened 146 79 62 26 23 7 3 0 346
Recalled 8 7 8 1 0 1 0 0 25
Ages
40+ Screened 55,178 35,907 32,472 13,226 10,722 2,975 2,309 1,254 154,043
Recalled 3,999 3,098 3,037 1,478 510 348 195 54 12,719
Ages
5069 Screened 26,766 24,229 14,497 7,244 5,876 1,353 1,061 614 81,640
Recalled 2,078 2,146 1,446 795 287 157 107 21 7,037
Source: BreastScreen Australia.
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Table 30: Age-specific and age-standardised recall to assessment rate, first screening round, states
and territories, 2001
Age
group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4044 6.1 7.4 8.3 10.1 3.9 11.5 4.2 5.4 7.1
4549 7.4 8.7 9.8 12.9 5.3 12.9 9.3 4.5 8.7
5054 8.2 9.1 10.8 11.6 4.7 12.6 9.4 3.0 8.9
5559 7.7 9.1 9.1 10.0 5.1 9.6 12.0 3.0 8.4
6064 7.5 8.7 9.5 9.5 6.5 12.9 11.8 4.4 8.5
6569 6.6 7.8 9.1 10.5 5.2 8.6 8.3 7.5 7.7
7074 7.0 9.0 7.9 12.7 5.2 6.7 12.1 10.5 8.0
7579 8.5 7.1 8.2 7.2 4.8 8.3 8.3 8.3 7.9
8084 5.7 7.5 10.6 4.6 1.7 13.3 12.5 0.0 6.8
85+ 5.5 8.9 12.9 3.8 0.0 14.3 0.0 . . 7.2
Ages 40+
Crude
rate 7.2 8.6 9.4 11.2 4.8 11.7 8.4 4.3 8.3
ASR(A) 7.4 8.6 9.4 10.8 5.1 10.9 9.9 4.9 8.3
95% CI 7.17.7 8.38.9 9.09.8 10.111.5 4.55.8 9.512.3 8.012.0 3.26.9 8.18.5
Ages
5069
Crude
rate 7.8 8.9 10.0 11.0 4.9 11.6 10.1 3.4 8.6
ASR(A) 7.6 8.7 9.7 10.5 5.3 11.1 10.4 4.2 8.5
95% CI 7.27.9 8.49.1 9.210.2 9.711.3 4.46.1 9.212.9 8.212.9 2.26.3 8.28.7
. . Not applicableno women in this age group screened in 2001.
Note: Rates are the number of women recalled for assessment as the percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Table 31: Numbers of women screened and women recalled for assessment by age, subsequent
screening rounds, states and territories, 2001
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 9,566 1,043 7,416 1,576 1,306 579 320 140 21,946
Recalled 344 37 367 82 31 48 16 2 927
4549 Screened 27,560 4,864 18,966 5,751 4,500 2,202 1,265 450 65,558
Recalled 1,143 244 1,080 259 118 140 57 17 3,058
5054 Screened 42,463 33,227 27,509 13,287 12,811 3,753 2,582 850 136,482
Recalled 1,590 1,428 1,395 533 306 235 115 16 5,618
5559 Screened 43,815 35,834 25,492 13,297 13,714 3,714 2,293 781 138,940
Recalled 1,663 1,394 1,245 473 275 190 130 13 5,383
6064 Screened 38,086 28,665 20,732 11,420 12,002 3,279 1,728 478 116,390
Recalled 1,393 1,126 969 434 302 189 78 10 4,501
6569 Screened 32,482 23,452 16,955 9,247 9,635 2,754 1,250 241 96,016
Recalled 1,147 903 776 341 237 108 77 5 3,594
7074 Screened 26,911 19,791 13,530 2,468 3,436 1,095 266 137 67,634
Recalled 893 670 641 84 98 62 14 1 2,463
7579 Screened 16,146 5,104 5,879 914 1,308 283 109 50 29,793
Recalled 503 185 264 47 47 15 3 2 1,066
8084 Screened 5,259 648 1,915 198 301 61 34 26 8,442
Recalled 160 20 82 7 11 3 4 0 287
85+ Screened 1,147 142 429 42 38 8 4 2 1,812
Recalled 39 5 21 2 2 1 1 0 71
Ages
40+ Screened 243,435 152,770 138,823 58,200 59,051 17,728 9,851 3,155 683,013
Recalled 8,875 6,012 6,840 2,262 1,427 991 495 66 26,968
Ages
5069 Screened 156,846 121,178 90,688 47,251 48,162 13,500 7,853 2,350 487,828
Recalled 5,793 4,851 4,385 1,781 1,120 722 400 44 19,096
 Source: BreastScreen Australia.
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Table 32: Age-specific and age-standardised recall to assessment rates, subsequent screening
rounds, states and territories, 2001
Age
group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4044 3.6 3.5 4.9 5.2 2.4 8.3 5.0 1.4 4.2
4549 4.1 5.0 5.7 4.5 2.6 6.4 4.5 3.8 4.7
5054 3.7 4.3 5.1 4.0 2.4 6.3 4.5 1.9 4.1
5559 3.8 3.9 4.9 3.6 2.0 5.1 5.7 1.7 3.9
6064 3.7 3.9 4.7 3.8 2.5 5.8 4.5 2.1 3.9
6569 3.5 3.9 4.6 3.7 2.5 3.9 6.2 2.1 3.7
7074 3.3 3.4 4.7 3.4 2.9 5.7 5.3 0.7 3.6
7579 3.1 3.6 4.5 5.1 3.6 5.3 2.8 4.0 3.6
8084 3.0 3.1 4.3 3.5 3.7 4.9 11.8 0.0 3.4
85+ 3.4 3.5 4.9 4.8 5.3 12.5 25.0 0.0 3.9
Ages 40+
Crude
rate 3.6 3.9 4.9 3.9 2.4 5.6 5.0 2.1 3.9
ASR(A) 3.7 4.0 4.9 4.0 2.5 5.8 5.1 2.1 4.0
95% CI 3.63.8 3.94.2 4.85.0 3.84.2 2.32.6 5.46.1 4.55.6 1.52.6 4.04.1
Ages
5069
Crude
rate 3.7 4.0 4.8 3.8 2.3 5.3 5.1 1.9 3.9
ASR(A) 3.7 4.0 4.8 3.8 2.3 5.4 5.1 1.9 3.9
95% CI 3.63.8 3.94.1 4.75.0 3.64.0 2.22.5 5.05.8 4.65.6 1.42.5 3.94.0
Note: Rates are the number of women recalled for assessment as the percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 6: Rescreen rate
Table 33: Number of women screened during 1999 and number of those women who returned for
screening within 27 months by age, first screening round, states and territories
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 14,299 4,948 9,523 2,530 2,339 840 591 243 35,313
Returned 8,882 775 7,099 1,546 1,329 613 275 135 20,654
4549 Screened 11,839 6,064 7,267 2,880 2,503 683 621 284 32,141
Returned 7,263 2,604 5,465 1,817 1,553 486 295 152 19,635
5054 Screened 13,168 13,434 9,323 2,334 4,737 886 743 444 45,069
Returned 8,238 9,809 7,131 1,381 3,322 641 389 217 31,128
5559 Screened 6,154 2,594 5,221 1,012 1,319 360 228 139 17,027
Returned 3,822 1,767 4,085 615 871 255 115 60 11,590
6064 Screened 4,743 2,038 3,905 677 855 284 135 91 12,728
Returned 3,048 1,398 3,141 410 591 214 61 41 8,904
6569 Screened 3,594 1,451 3,300 479 666 191 94 48 9,823
Returned 2,231 1,016 2,593 219 288 115 26 19 6,507
7074 Screened 2,199 858 1,822 302 259 115 61 27 5,643
Returned 1,366 487 1,312 57 47 29 5 10 3,313
7579 Screened 1,539 678 1,073 204 241 94 30 12 3,871
Returned 942 47 484 29 50 14 3 4 1,573
8084 Screened 497 221 355 49 83 22 12 5 1,244
Returned 255 12 129 4 8 4 1 3 416
85+ Screened 122 66 106 12 22 5 2 0 335
Returned 48 3 26 2 2 1 0 0 82
Ages
40+ Screened 58,154 32,352 41,895 10,479 13,024 3,480 2,517 1,293 163,194
Returned 36,095 17,918 31,465 6,080 8,061 2,372 1,170 641 103,802
Ages
5069 Screened 27,659 19,517 21,749 4,502 7,577 1,721 1,200 722 84,647
Returned 17,339 13,990 16,950 2,625 5,072 1,225 591 337 58,129
Source: BreastScreen Australia.
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Table 34: Age-specific and age-standardised rescreen rates for women screened during 1999, first
screening round, states and territories
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4044 62.1 15.7 74.5 61.1 56.8 73.0 46.5 55.6 58.5
4549 61.3 42.9 75.2 63.1 62.0 71.2 47.5 53.5 61.1
5054 62.6 73.0 76.5 59.2 70.1 72.3 52.4 48.9 69.1
5559 62.1 68.1 78.2 60.8 66.0 70.8 50.4 43.2 68.1
6064 64.3 68.6 80.4 60.6 69.1 75.4 45.2 45.1 70.0
6569 62.1 70.0 78.6 45.7 43.2 60.2 27.7 39.6 66.2
7074 62.1 56.8 72.0 18.9 18.1 25.2 8.2 37.0 58.7
7579 61.2 6.9 45.1 14.2 20.7 14.9 10.0 33.3 40.6
8084 51.3 5.4 36.3 8.2 9.6 18.2 8.3 60.0 33.4
85+ 39.3 4.5 24.5 16.7 9.1 20.0 0.0 . . 24.5
Ages 40+
Crude rate 62.1 55.4 75.1 58.0 61.9 68.2 46.5 49.6 63.6
ASR(A) 62.3 58.6 75.6 53.3 57.2 64.6 41.2 45.8 64.7
95% CI 61.862.7 58.059.3 75.176.0 52.254.4 56.258.2 62.766.4 38.943.5 42.449.2 64.465.0
Ages
5069
Crude rate 62.7 71.7 77.9 58.3 66.9 71.2 49.3 46.7 68.7
ASR(A) 62.7 70.2 78.2 57.3 63.6 70.3 45.5 44.7 68.5
95% CI 62.163.3 69.471.0 77.678.8 55.758.8 62.464.9 68.072.5 42.348.7 40.349.0 68.068.8
. . Not applicableno women in this age group screened in 1999.
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Table 35: Number of women screened during 1999 and number of those women who returned for
screening within 27 months by age, second screening round, states and territories
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 6,490 1,052 4,610 1,050 760 404 229 135 14,730
Returned 4,751 381 3,847 790 572 323 146 83 10,893
4549 Screened 10,440 3,291 6,629 2,794 1,738 691 444 270 26,297
Returned 7,497 1,834 5,541 2,111 1,278 549 251 185 19,246
5054 Screened 16,973 17,802 9,070 5,167 4,276 1,030 752 515 55,585
Returned 12,621 14,579 7,792 3,840 3,385 828 466 323 43,834
5559 Screened 10,279 6,190 6,705 2,740 2,134 572 397 358 29,375
Returned 7,501 4,874 5,809 2,049 1,651 446 219 235 22,784
6064 Screened 8,515 4,269 5,163 2,129 1,363 415 209 183 22,246
Returned 6,307 3,406 4,519 1,618 1,066 329 126 129 17,500
6569 Screened 7,118 3,479 4,225 1,650 1,054 307 146 108 18,087
Returned 5,175 2,669 3,627 927 581 195 51 70 13,295
7074 Screened 5,064 2,509 2,757 447 424 125 55 66 11,447
Returned 3,541 1,599 2,177 140 127 31 6 41 7,662
7579 Screened 2,692 845 1,442 227 299 86 55 21 5,667
Returned 1,856 141 726 73 98 20 6 12 2,932
8084 Screened 926 208 418 51 66 21 4 11 1,705
Returned 540 29 173 20 14 4 1 7 788
85+ Screened 160 54 89 6 7 1 3 0 320
Returned 76 8 27 0 1 0 0 0 112
Ages
40+ Screened 68,657 39,699 41,108 16,261 12,121 3,652 2,294 1,667 185,459
Returned 49,865 29,520 34,238 11,568 8,773 2,725 1,272 1,085 139,046
Ages
5069 Screened 42,885 31,740 25,163 11,686 8,827 2,324 1,504 1,164 125,293
Returned 31,604 25,528 21,747 8,434 6,683 1,798 862 757 97,413
Source: BreastScreen Australia.
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Table 36: Age-specific and age-standardised rescreen rates in women screened during 1999, second
screening round, states and territories
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4044 73.2 36.2 83.4 75.2 75.3 80.0 63.8 61.5 74.0
4549 71.8 55.7 83.6 75.6 73.5 79.5 56.5 68.5 73.2
5054 74.4 81.9 85.9 74.3 79.2 80.4 62.0 62.7 78.9
5559 73.0 78.7 86.6 74.8 77.4 78.0 55.2 65.6 77.6
6064 74.1 79.8 87.5 76.0 78.2 79.3 60.3 70.5 78.7
6569 72.7 76.7 85.8 56.2 55.1 63.5 34.9 64.8 73.5
7074 69.9 63.7 79.0 31.3 30.0 24.8 10.9 62.1 66.9
7579 68.9 16.7 50.3 32.2 32.8 23.3 10.9 57.1 51.7
8084 58.3 13.9 41.4 39.2 21.2 19.0 25.0 63.6 46.2
85+ 47.5 14.8 30.3 0.0 14.3 0.0 0.0 . . 35.0
Ages 40+
Crude rate 72.6 74.4 83.3 71.1 72.4 74.6 55.4 65.1 75.0
ASR(A) 72.7 69.2 83.6 67.2 68.4 70.4 50.2 65.1 75.0
95% CI 72.473.1 68.669.7 83.384.0 66.467.9 67.669.2 68.971.8 48.152.3 62.767.3 74.775.3
Ages
5069
Crude rate 73.7 80.4 86.4 72.2 75.7 77.4 57.3 65.0 77.7
ASR(A) 73.6 79.6 86.4 71.3 73.8 76.2 54.6 65.0 77.7
95% CI 73.274.0 79.180.1 86.086.9 70.572.1 72.874.8 74.478.0 51.657.2 62.467.7 77.378.2
. . Not applicableno women in this age group screened in 1999.
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Table 37: Number of women screened during 1999 and number of those women who returned for
screening within 27 months by age, third and subsequent screening rounds, states and territories
Age
group Number NSW Vic Qld WA SA Tas ACT NT Australia
4044 Screened 2,132 169 1,751 396 228 187 99 26 4,988
Returned 1,783 96 1,569 324 200 158 73 23 4,226
4549 Screened 13,994 1,801 9,161 2,442 2,430 1,548 990 153 32,519
Returned 11,203 1,245 8,181 2,032 2,047 1,329 703 115 26,855
5054 Screened 21,948 13,831 12,396 6,562 6,456 2,349 1,690 230 65,462
Returned 18,066 11,968 11,224 5,589 5,599 2,063 1,225 186 55,920
5559 Screened 28,051 23,947 12,605 8,195 9,561 2,792 1,746 340 87,237
Returned 23,208 20,907 11,521 7,003 8,379 2,469 1,269 259 75,015
6064 Screened 25,545 21,235 11,184 7,406 9,089 2,544 1,405 185 78,593
Returned 21,665 18,844 10,316 6,402 8,060 2,289 1,073 144 68,793
6569 Screened 22,697 18,778 9,488 6,313 7,782 2,221 1,075 96 68,450
Returned 19,037 16,317 8,594 4,230 5,267 1,615 555 69 55,684
7074 Screened 19,042 15,548 7,813 1,433 2,498 383 198 42 46,957
Returned 15,523 11,253 6,412 717 1,312 211 66 30 35,524
7579 Screened 8,986 2,771 4,119 442 559 100 71 10 17,058
Returned 6,941 560 2,283 212 301 50 27 8 10,382
8084 Screened 2,700 209 1,243 71 104 16 7 7 4,357
Returned 1,798 68 623 34 54 6 0 3 2,586
85+ Screened 339 38 269 10 11 1 3 0 917
Returned 290 9 103 5 4 1 0 0 414
Ages
40+ Screened 145,434 98,327 70,029 33,270 38,718 12,141 7,284 1,089 406,538
Returned 119,514 81,267 60,826 26,548 31,223 10,191 4,991 837 335,399
Ages
5069 Screened 98,241 77,791 45,673 28,476 32,888 9,906 5,916 851 299,742
Returned 81,976 68,036 41,655 23,224 27,305 8,436 4,122 658 255,412
Source: BreastScreen Australia.
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Table 38: Age-specific and age-standardised rescreen rates in women screened during 1999, third
and subsequent screening rounds, states and territories
Age Group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent)
4044 83.6 56.8 89.6 81.8 87.7 84.5 73.7 88.5 84.7
4549 80.1 69.1 89.3 83.2 84.2 85.9 71.0 75.2 82.6
5054 82.3 86.5 90.5 85.2 86.7 87.8 72.5 80.9 85.4
5559 82.7 87.3 91.4 85.5 87.6 88.4 72.7 76.2 86.0
6064 84.8 88.7 92.2 86.4 88.7 90.0 76.4 77.8 87.5
6569 83.9 86.9 90.6 67.0 67.7 72.7 51.6 71.9 81.3
7074 81.5 72.4 82.1 50.0 52.5 55.1 33.3 71.4 75.7
7579 77.2 20.2 55.4 48.0 53.8 50.0 38.0 80.0 60.9
8084 66.6 32.5 50.1 47.9 51.9 37.5 0.0 42.9 59.4
85+ 85.5 23.7 38.3 50.0 36.4 100.0 0.0 . . 45.1
Ages 40+
Crude rate 82.2 82.6 86.9 79.8 80.6 83.9 68.5 76.9 82.5
ASR(A) 82.4 82.6 88.5 78.1 80.2 83.9 65.2 76.9 82.5
95% CI 82.282.7 82.482.9 88.288.7 77.578.6 79.780.7 83.384.6 63.966.5 74.479.3 82.282.7
Ages
5069
Crude rate 83.4 87.5 91.2 81.6 83.0 85.2 69.7 77.3 85.2
ASR(A) 83.3 87.5 91.1 82.0 83.7 85.5 69.3 77.3 85.2
95% CI 83.083.5 87.287.7 90.991.4 81.582.4 83.384.1 84.886.2 68.170.5 74.580.1 84.985.5
. . Not applicableno women screened in this age group in 1999.
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of
women attending a BreastScreen Australia service in 1998.
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 7a: Incidence of breast cancer
Table 39: Number of new cases of breast cancer in women by age, Australia, 19872000
Age
group 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
04 0 0 0 0 0 0 0 0 0 0 0 0 0 0
59 0 0 0 0 0 0 0 0 1 0 0 0 0 0
1014 0 0 0 0 0 0 1 0 1 0 0 0 0 0
1519 1 0 0 0 0 0 0 0 1 1 3 4 0 2
2024 5 7 8 4 11 6 13 7 8 6 13 13 11 4
2529 59 46 44 52 53 46 58 57 58 42 52 53 49 54
3034 192 165 158 204 184 179 169 200 203 197 175 197 186 190
3539 363 345 367 341 402 380 414 395 399 426 446 419 441 436
4044 592 654 656 669 717 712 779 773 757 765 757 850 824 840
4549 691 671 754 826 854 1,010 1,027 1,140 1,233 1,187 1,156 1,167 1,150 1,269
5054 600 633 728 786 856 856 977 1,108 1,240 1,188 1,330 1,471 1,497 1,562
5559 692 635 681 690 809 819 926 1,030 1,147 1,123 1,174 1,272 1,300 1,433
6064 823 851 885 826 889 789 975 1,101 1,063 1,020 1,075 1,144 1,243 1,339
6569 768 769 830 854 951 929 998 1,209 1,100 1,066 1,075 1,144 1,091 1,118
7074 626 699 713 754 792 775 900 1,019 1,004 983 1,029 1,055 986 1,100
7579 583 576 623 634 670 657 692 781 852 739 864 886 836 891
8084 390 385 395 424 485 490 469 525 580 562 572 588 546 567
85+ 306 300 327 336 371 365 394 376 412 436 444 491 484 511
All
ages 6,691 6,736 7,169 7,400 8,044 8,013 8,792 9,721 10,059 9,741 10,165 10,754 10,644 11,316
Ages
5069 2,883 2,888 3,124 3,156 3,505 3,393 3,876 4,448 4,550 4,397 4,654 5,031 5,131 5,452
Source: AIHW National Cancer Statistics Clearing House.
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Table 40: Age-specific and age-standardised incidence rates for breast cancer in women, Australia,
19872000
Age
group 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
59 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0
1014 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0
1519 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.6 0.0 0.3
2024 0.8 1.1 1.2 0.6 1.6 0.9 1.8 1.0 1.1 0.9 1.9 2.0 1.7 0.6
2529 8.6 6.6 6.2 7.4 7.6 6.7 8.5 8.4 8.4 5.9 7.2 7.2 6.7 7.4
3034 29.7 25.0 23.3 29.4 25.8 24.7 23.1 27.2 27.8 27.2 24.4 27.8 26.2 26.5
3539 58.1 54.4 56.8 51.9 60.5 56.1 60.2 56.6 56.0 58.4 60.0 55.7 58.2 57.6
4044 110.5 114.7 110.1 108.1 112.2 111.0 120.4 117.6 113.4 112.7 109.4 121.0 115.3 115.2
4549 163.9 154.2 165.4 172.6 169.9 187.5 179.2 191.3 200.0 185.6 179.9 178.5 172.9 188.2
5054 163.0 167.7 187.1 196.1 207.2 201.8 225.1 244.6 260.5 238.8 247.6 256.9 250.4 250.7
5559 188.4 174.7 188.6 192.1 225.6 223.5 246.4 267.1 290.0 275.6 278.7 293.4 287.2 302.7
6064 223.4 230.0 238.8 222.8 240.2 216.0 271.1 308.5 297.9 286.0 295.6 307.1 323.5 337.4
6569 242.9 233.5 242.1 245.0 270.7 263.2 280.8 341.1 310.6 300.5 305.2 327.8 315.2 324.0
7074 234.3 261.3 268.2 278.6 280.6 264.9 296.5 321.1 310.9 300.6 313.1 318.7 295.8 329.7
7579 293.2 279.8 290.1 287.3 297.1 286.8 300.8 342.8 365.0 303.1 336.9 329.6 297.6 309.7
8084 315.1 298.3 295.2 304.3 333.5 323.5 296.3 314.1 336.4 318.2 318.0 323.0 298.3 298.4
85+ 314.8 300.6 316.8 318.2 337.2 315.6 323.4 294.9 306.7 307.9 297.3 313.2 291.4 291.7
All Ages
Crude
rate 82.1 81.3 85.1 86.5 92.8 91.3 99.1 108.4 110.8 105.8 109.1 114.2 111.7 117.3
ASR(A) 91.2 89.7 93.5 94.6 100.4 98.0 105.3 113.9 115.7 109.2 111.2 114.9 111.2 115.4
Ages
5069
Crude
rate 203.1 200.5 213.4 213.4 234.7 224.9 254.2 286.9 287.5 272.0 278.0 291.2 288.1 296.5
ASR(A) 197.1 194.8 208.5 209.6 230.5 221.6 250.6 281.6 285.3 269.7 276.5 290.1 287.5 296.2
Note: Rates are the number of cases of invasive cancers per 100,000 women and age-standardised to the Australian population at 30 June 2001.
Source: AIHW National Cancer Statistics Clearing House.
94
Table 41: Number of new cases of breast cancer in women by age, states and territories, 19972000
Age group NSW Vic Qld WA SA Tas ACT NT Australia
04 0 0 0 0 0 0 0 0 0
59 0 0 0 0 0 0 0 0 0
1014 0 0 0 0 0 0 0 0 0
1519 0 2 4 3 0 0 0 0 9
2024 17 10 5 3 5 1 0 0 41
2529 60 60 41 25 10 5 4 3 208
3034 245 198 131 81 62 15 14 2 748
3539 584 421 331 186 148 31 26 15 1,742
4044 1,112 838 589 301 268 75 57 31 3,271
4549 1,575 1,178 873 475 426 101 80 34 4,742
5054 1,967 1,460 1,034 533 546 157 128 35 5,860
5559 1,775 1,241 963 474 475 128 93 30 5,179
6064 1,619 1,227 891 436 419 126 67 16 4,801
6569 1,486 1,169 806 407 394 95 61 10 4,428
7074 1,482 1,143 767 297 323 98 48 12 4,170
7579 1,210 926 592 298 323 87 34 7 3,477
8084 754 612 415 183 235 48 24 2 2,273
85+ 638 545 326 163 190 46 17 5 1,930
All ages 14,524 11,030 7,768 3,865 3,824 1,013 653 202 42,879
Ages 5069 6,847 5,097 3,694 1,850 1,834 506 349 91 20,268
Source: AIHW National Cancer Statistics Clearing House.
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Table 42: Age-specific and age-standardised incidence rates for breast cancer in women, states and
territories, 19972000
Age
group NSW Vic Qld WA SA Tas ACT NT Australia
04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
59 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1014 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1519 0.0 0.3 0.8 1.2 0.0 0.0 0.0 0.0 0.4
2024 2.0 1.5 1.0 1.2 2.6 1.7 0.0 0.0 1.6
2529 6.1 8.1 7.6 8.9 4.7 7.7 7.5 7.9 7.1
3034 25.5 27.1 25.2 28.9 28.7 22.6 27.9 5.8 26.2
3539 57.3 56.4 59.9 62.6 63.1 41.3 50.1 46.5 57.9
4044 116.7 119.1 113.5 105.2 119.1 104.4 113.4 109.7 115.3
4549 179.2 180.3 179.9 180.6 198.8 151.7 162.1 139.6 179.9
5054 250.8 251.8 239.1 241.2 282.1 264.3 307.0 189.8 251.4
5559 290.9 278.4 296.0 285.4 321.7 272.1 342.5 259.9 290.8
6064 306.3 315.4 337.2 315.6 323.0 309.9 337.7 227.8 316.4
6569 301.6 325.0 339.1 335.5 320.6 253.4 381.7 213.9 318.0
7074 313.4 330.6 345.6 271.9 261.3 278.3 325.6 368.6 314.3
7579 309.6 327.1 323.8 336.8 308.5 289.9 287.3 324.1 317.9
8084 286.3 324.2 336.7 305.8 335.0 229.8 327.4 151.3 309.3
85+ 280.5 317.1 308.0 294.9 301.0 267.7 303.8 489.2 298.1
All ages
Crude
rate 113.0 116.6 111.6 105.7 126.6 105.9 103.8 55.6 113.1
ASR(A) 111.1 114.4 116.0 111.8 117.7 102.5 120.7 96.2 113.2
95% CI 109.3113.0 112.1116.4 113.4118.6 108.3115.2 113.8121.7 96.3108.8 110.5129.8 81.6111.9 112.0114.2
Ages
5069
Crude
rate 283.4 287.3 293.2 286.1 308.9 274.1 333.4 218.3 288.7
ASR(A) 282.5 285.7 293.2 285.8 308.3 274.2 336.3 220.9 287.8
95% CI 275.7289.6 278.0293.5 284.0303.3 272.7298.6 294.1323.1 250.6298.1 298.6370.2 173.0267.9 283.7291.7
Note: Rates are the number of cases of invasive cancers per 100,000 women and age-standardised to the Australian population at 30 June 2001.
Source: AIHW National Cancer Statistics Clearing House.
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Table 43: Number of new cases of breast cancer in women, by age and region, 19962000
Age group Capital cities
Other
metropolitan
centres
Large rural
centres
Small rural
centres
Other rural
areas
Remote
areas Australia
04 0 0 0 0 0 0 0
59 0 0 0 0 0 0 0
1014 0 0 0 0 0 0 0
1519 7 0 0 1 2 0 10
2024 34 6 2 2 4 0 47
2529 178 19 13 10 24 5 250
3034 668 57 41 47 110 21 943
3539 1,440 160 114 128 269 53 2,163
4044 2,672 303 261 228 473 96 4,033
4549 3,959 391 341 335 764 131 5,921
5054 4,717 493 361 409 922 137 7,039
5559 4,016 514 325 417 910 110 6,293
6064 3,616 454 367 417 872 87 5,812
6569 3,410 450 341 438 776 72 5,486
7074 3,213 466 319 380 694 74 5,146
7579 2,661 347 272 333 551 50 4,214
8084 1,833 234 177 170 379 38 2,831
85+ 1,522 179 163 163 310 25 2,362
All ages 33,946 4,073 3,097 3,478 7,060 899 52,550
Ages 5069 15,759 1,911 1,394 1,681 3,480 406 24,630
Source: AIHW National Cancer Statistics Clearing House.
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Table 44: Age-specific and age-standardised incidence rates for breast cancer in women by region,
19962000
Age group Capital cities
Other
metropolitan
centres
Large rural
centres
Small rural
centres
Other rural
areas
Remote
areas Australia
04 0.0 0.0 0.0 0.0 0.0 0.0 0.0
59 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1014 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1519 0.3 0.0 0.0 0.5 0.5 0.0 0.3
2024 1.5 2.4 1.0 1.2 1.4 0.0 1.4
2529 7.2 7.2 6.3 5.2 6.7 4.2 6.9
3034 28.1 22.2 20.4 22.9 26.0 18.2 26.4
3539 59.9 58.5 52.5 54.5 54.1 47.3 57.9
4044 118.4 117.0 126.2 101.5 100.1 100.5 114.7
4549 186.1 160.7 182.2 163.9 177.0 161.4 180.8
5054 259.2 228.8 228.0 227.1 237.9 204.8 248.9
5559 295.7 296.9 257.2 271.4 278.0 221.0 287.6
6064 317.3 294.2 323.8 289.9 305.7 233.6 310.2
6569 321.3 296.2 314.0 310.3 305.0 242.4 314.0
7074 314.3 317.6 304.9 285.7 309.8 321.7 311.2
7579 316.5 300.0 315.5 318.9 316.4 302.7 315.0
8084 318.8 309.9 287.7 247.4 317.2 335.8 310.6
85+ 300.9 298.1 309.1 293.2 297.3 238.1 299.4
All ages
Crude rate 112.6 113.2 108.6 112.7 115.4 69.0 111.6
ASR(A) 115.2 108.4 109.4 104.2 108.9 95.5 112.3
95% CI 114.0116.4 105.2112.0 105.5113.3 100.8107.7 106.4111.5 88.7101.9 111.3113.2
Ages 5069
Crude rate 293.0 274.9 275.0 271.9 277.4 221.2 285.2
ASR(A) 292.5 273.0 271.8 267.2 275.1 222.0 284.0
95% CI 288.0296.9 260.8285.4 257.0286.0 253.9279.6 265.7284.6 201.3244.2 280.2287.7
Note: Rates are the number of cases of invasive cancers per 100,000 women and age-standardised to the Australian population at 30 June 2001.
Source: AIHW National Cancer Statistics Clearing House.
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Indicator 7b: Incidence of ductal carcinoma in situ
Table 45: Number of new cases of ductal carcinoma in situ by age, states and territories, 19952000
Age group NSW Vic Qld WA SA Tas ACT NT Australia
019 0 n.a. 1 n.a. 0 0 0 0 n.a.
2029 11 n.a. 2 n.a. 2 0 1 0 n.a.
3039 86 n.a. 45 n.a. 16 5 2 2 n.a.
4049 461 n.a. 203 n.a. 100 24 28 9 n.a.
5059 644 n.a. 320 n.a. 208 68 34 8 n.a.
6069 510 n.a. 266 n.a. 148 37 18 6 n.a.
70+ years 442 n.a. 184 n.a. 99 20 24 1 n.a.
All ages 2,154 n.a. 1,021 n.a. 573 154 107 26 n.a.
Ages 5069 1,154 n.a. 586 n.a. 356 105 52 14 n.a.
n.a. Not available.
Source: AIHW National Cancer Statistics Clearing House.
Table 46: Age-specific and age-standardised rates of ductal carcinoma in situ, states and
territories, 19952000
Age group NSW Vic Qld WA SA Tas ACT NT Australia
019 0.0 n.a.  0.0 n.a. 0.0 0.0 0.0 0.0 n.a.
2029 0.4 n.a. 0.1 n.a. 0.3 0.0 0.6 0.0 n.a.
3039 2.9 n.a. 2.8 n.a. 2.3 2.3 1.3 2.0 n.a.
4049 17.1 n.a. 13.8 n.a. 15.3 11.7 18.8 11.8 n.a.
5059 32.1 n.a. 29.8 n.a. 42.4 44.2 35.1 19.1 n.a.
6069 33.4 n.a. 35.9 n.a. 39.0 31.7 34.4 35.6 n.a.
70+ years 22.3 n.a. 19.9 n.a. 18.7 13.1 42.4 9.0 n.a.
All ages
Crude rate 11.3 n.a. 10.0 n.a. 12.7 10.7 11.4 4.9 n.a.
AS Rate (A) 11.4 n.a. 10.6 n.a. 12.4 11.0 13.7 7.9 n.a.
95% CI 10.911.9 n.a. 9.911.2 n.a. 11.413.4 9.112.7 11.216.4 4.711.3 n.a.
Ages 5069
Crude rate 32.7 n.a. 32.3 n.a. 40.9 38.8 34.9 23.9 n.a.
AS Rate (A) 32.6 n.a. 32.2 n.a. 41.1 39.3 34.8 25.6 n.a.
95% CI 30.834.6 n.a. 29.534.8 n.a. 36.645.3 31.546.6 25.544.7 12.840.2 n.a.
n.a. Not available.
Note: Rates are the number of cases of DCIS per 100,000 women and age-standardised to the Australian population at 30 June 2001.
Source: AIHW National Cancer Statistics Clearing House.
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Indicator 8: Mortality
Table 47: Number of deaths from breast cancer in women, Australia, 19872001
Age
group 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
59 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2024 2 0 1 0 2 1 0 1 1 0 1 2 2 1 1
2529 10 5 7 6 12 4 2 2 5 9 6 7 6 5 2
3034 30 26 34 26 25 33 39 19 25 28 37 28 20 23 21
3539 75 66 67 63 79 79 74 87 57 90 84 68 59 66 63
4044 123 120 137 149 150 136 116 139 120 136 135 128 141 122 126
4549 129 152 170 168 177 196 202 211 207 189 211 207 203 187 185
5054 206 202 212 228 232 212 225 239 221 230 271 265 247 255 262
5559 244 238 217 215 227 219 252 249 248 240 236 227 260 257 253
6064 270 291 287 282 258 236 276 262 268 258 239 255 263 239 228
6569 254 290 297 328 306 272 316 290 317 289 284 252 212 216 242
7074 257 251 251 258 305 287 264 308 288 296 297 268 288 287 315
7579 230 254 261 254 249 254 298 274 281 279 291 300 274 281 289
8084 166 184 205 205 211 213 257 250 259 252 244 236 232 237 273
85+ 217 222 238 219 229 247 268 271 280 273 273 314 298 335 325
All
ages 2,213 2,301 2,384 2,401 2,462 2,389 2,590 2,602 2,577 2,569 2,609 2,557 2,505 2,511 2,585
Ages
5069 974 1,021 1,013 1,053 1,023 939 1,069 1,040 1,054 1,017 1,030 999 982 967 985
Source: AIHW National Mortality Database.
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Table 48: Age-specific and age-standardised mortality rates for breast cancer in women, Australia,
19872001
Age
group 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
59 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1014 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1519 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
2024 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.2 0.2
2529 1.5 0.7 1.0 0.8 1.7 0.6 0.3 0.3 0.7 1.3 0.8 1.0 0.8 0.7 0.3
3034 4.6 3.9 5.0 3.7 3.5 4.6 5.3 2.6 3.4 3.9 5.2 3.9 2.8 3.2 2.8
3539 12.0 10.4 10.4 9.6 11.9 11.7 10.8 12.5 8.0 12.3 11.3 9.0 7.8 8.7 8.4
4044 23.0 21.1 23.0 24.1 23.5 21.2 17.9 21.2 18.0 20.0 19.5 18.2 19.7 16.7 16.9
4549 30.6 34.9 37.3 35.1 35.2 36.4 35.3 35.4 33.6 29.5 32.8 31.7 30.5 27.7 27.1
5054 56.0 53.5 54.5 56.9 56.2 50.0 51.8 52.8 46.4 46.2 50.4 46.3 41.3 40.9 40.4
5559 66.4 65.5 60.1 59.9 63.3 59.8 67.1 64.6 62.7 58.9 56.0 52.4 57.4 54.3 51.0
6064 73.3 78.6 77.4 76.1 69.7 64.6 76.8 73.4 75.1 72.3 65.7 68.5 68.4 60.2 55.9
6569 80.3 88.1 86.6 94.1 87.1 77.1 88.9 81.8 89.5 81.5 80.6 72.2 61.3 62.6 69.8
7074 96.2 93.8 94.4 95.3 108.1 98.1 87.0 97.1 89.2 90.5 90.4 80.9 86.4 86.0 94.1
7579 115.7 123.4 121.5 115.1 110.4 110.9 129.5 120.3 120.4 114.4 113.5 111.6 97.6 97.7 99.0
8084 134.1 142.6 153.2 147.1 145.1 140.6 162.4 149.5 150.2 142.7 135.7 129.6 126.7 124.7 135.3
85+ 223.3 222.4 230.6 207.4 208.1 213.6 219.9 212.5 208.4 192.8 182.8 200.3 179.4 191.3 177.3
All ages
Crude
rate 27.2 27.8 28.3 28.1 28.4 27.2 29.2 29.0 28.4 27.9 28.0 27.2 26.3 26.0 26.4
ASR(A) 30.0 30.5 30.8 30.4 30.5 28.9 30.5 30.0 28.9 28.1 27.8 26.5 25.4 24.7 24.7
Ages
5069
Crude
rate 68.6 70.9 69.2 71.2 68.5 62.2 70.1 67.1 66.6 62.9 61.5 57.8 55.1 52.6 51.9
ASR(A) 66.8 68.3 66.7 68.5 66.5 60.6 67.9 65.5 64.6 61.5 60.6 57.3 55.0 52.5 51.8
Note: Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001.
Source: AIHW National Mortality Database.
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Table 49: Number of deaths from breast cancer in women by age, states and territories, 19982001
Age group NSW Vic Qld WA SA Tas ACT NT Australia
04 0 0 0 0 0 0 0 0 0
59 0 0 0 0 0 0 0 0 0
1014 0 0 0 0 0 0 0 0 0
1519 0 0 0 0 0 0 0 0 0
2024 2 2 1 1 0 0 0 0 6
2529 5 7 4 3 1 0 0 0 20
3034 37 19 19 6 8 0 3 0 92
3539 75 77 42 23 24 10 4 1 256
4044 150 136 99 51 56 14 6 5 517
4549 255 208 131 73 67 22 16 10 782
5054 307 280 211 97 80 28 17 9 1,029
5559 331 269 182 83 79 25 21 7 997
6064 326 258 173 79 94 26 20 9 985
6569 351 229 126 77 86 30 19 4 922
7074 373 330 207 91 97 32 24 4 1,158
7579 378 312 195 104 97 40 16 2 1,144
8084 350 267 157 70 89 31 10 4 978
85+ 405 349 210 135 119 36 17 1 1,272
All ages 3,345 2,743 1,757 893 897 294 173 56 10,158
Ages 5069 1,315 1,036 692 336 339 109 77 29 3,933
Source: AIHW National Mortality Database.
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Table 50: Age-specific and age-standardised mortality rates for breast cancer in women, states and
territories, 19982001
Age group NSW Vic Qld WA SA Tas ACT NT Australia
04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
59 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1014 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1519 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
2024 0.2 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.2
2529 0.5 1.0 0.7 1.1 0.5 0.0 0.0 0.0 0.7
3034 3.8 2.6 3.6 2.1 3.7 0.0 6.0 0.0 3.2
3539 7.4 10.3 7.5 7.7 10.3 13.6 7.8 3.1 8.5
4044 15.4 19.0 18.6 17.5 24.6 19.3 11.9 17.4 17.9
4549 28.6 31.4 26.5 27.1 31.0 32.7 32.4 39.8 29.2
5054 37.6 46.2 46.3 41.3 39.6 45.2 38.5 45.4 42.1
5559 52.3 58.3 52.9 48.0 51.4 51.5 72.8 56.4 53.7
6064 60.2 64.9 62.6 55.1 71.0 62.1 96.0 119.6 63.1
6569 71.8 63.9 52.9 62.9 71.0 80.5 116.6 82.7 66.5
7074 78.7 95.2 92.1 81.8 78.9 91.1 161.7 117.7 86.9
7579 93.9 106.5 103.4 113.3 89.9 130.4 127.8 89.2 101.3
8084 128.9 137.8 122.9 114.3 123.3 145.5 128.2 280.5 129.2
85+ 169.4 193.5 187.8 230.6 179.7 198.9 278.0 91.3 186.7
All ages
Crude rate 25.7 28.7 24.8 24.0 29.5 30.7 27.2 15.2 26.5
ASR(A) 24.0 26.8 25.0 24.7 25.5 27.6 33.5 30.6 25.3
95% CI 23.224.8 25.827.8 23.926.1 23.126.4 23.827.3 24.330.7 28.338.5 21.641.0 24.825.8
Ages 5069
Crude rate 53.0 56.8 52.7 49.9 55.6 57.5 69.9 65.0 54.3
ASR(A) 52.5 56.6 52.8 49.9 55.1 56.8 73.9 71.0 54.1
95% CI 49.855.3 53.159.9 48.956.5 44.755.5 49.460.8 45.966.8 56.791.6 44.496.9 52.355.7
Note: Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001.
Source: AIHW National Mortality Database.
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Table 51: Number of deaths from breast cancer in women by age and region, 19972001
Age group Capital cities
Other
metropolitan
centres
Large rural
centres
Small rural
centres
Other rural
areas
Remote
 areas Australia
04 0 0 0 0 0 0 0
59 0 0 0 0 0 0 0
1014 0 0 0 0 0 0 0
1519 0 0 0 0 0 0 0
2024 4 1 1 0 1 0 7
2529 15 5 0 3 3 0 26
3034 78 10 8 12 17 4 129
3539 221 19 25 24 40 11 340
4044 404 34 41 42 107 23 651
4549 672 74 56 57 113 20 992
5054 819 79 101 85 193 23 1,300
5559 810 85 65 67 183 22 1,232
6064 758 97 58 80 209 22 1,224
6569 757 109 69 83 169 19 1,206
7074 920 112 80 117 202 24 1,455
7579 885 132 105 101 199 13 1,435
8084 798 105 79 83 143 14 1,222
85+ 967 124 107 116 214 17 1,545
All ages 8,108 986 795 870 1,793 212 12,764
Ages 5069 3,144 370 293 315 754 86 4,962
Source: AIHW National Mortality Database.
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Table 52: Age-specific and age-standardised mortality rates for breast cancer in women by region,
19972001
Age group
Capital
Cities
Other
metropolitan
Large rural
centres
Small rural
centres
Other rural
areas
Remote
areas Australia
04 0.0 0.0 0.0 0.0 0.0 0.0 0.0
59 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1014 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1519 0.0 0.0 0.0 0.0 0.0 0.0 0.0
2024 0.2 0.4 0.5 0.0 0.4 0.0 0.2
2529 0.6 1.9 0.0 1.6 0.9 0.0 0.7
3034 3.2 3.9 4.0 5.9 4.1 3.5 3.6
3539 9.1 6.8 11.5 10.2 8.1 9.8 9.0
4044 17.6 12.8 19.4 18.3 22.2 23.7 18.2
4549 31.3 29.8 29.3 27.3 25.6 24.2 29.9
5054 42.7 34.7 60.5 44.7 47.4 32.9 43.6
5559 57.3 46.9 49.5 41.9 53.8 42.7 54.1
6064 64.9 60.9 49.7 54.0 71.0 57.1 63.6
6569 71.9 72.2 63.6 58.7 66.2 63.2 69.3
7074 90.1 75.4 75.7 86.5 88.9 101.9 87.6
7579 101.9 109.0 117.5 92.6 110.3 76.3 103.5
8084 135.5 133.4 124.6 115.8 116.7 121.3 130.5
85+ 182.0 192.7 191.5 195.9 195.4 162.0 186.0
All ages
Crude rate 26.6 26.9 27.6 27.8 29.0 16.2 26.8
ASR(A) 26.1 24.2 26.1 24.1 26.3 23.2 25.8
95% CI 25.626.7 22.725.8 24.328.0 22.525.8 25.127.6 20.126.2 25.326.2
Ages 5069
Crude rate 56.6 51.5 56.0 49.3 58.1 45.2 55.6
ASR(A) 56.6 50.3 55.8 48.5 57.5 46.1 55.3
95% CI 54.658.5 45.355.2 49.362.4 43.153.6 53.461.7 36.855.8 53.756.8
Note: Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001.
Source: AIHW National Mortality Database.
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Table 53: Number of deaths from breast cancer in women by age and Indigenous status,
Queensland, Western Australia, South Australia, Northern Territory, 19972001
Age group Indigenous NonIndigenous Australia
04 0 0 0
59 0 0 0
1014 0 0 0
1519 0 0 0
2024 0 2 7
2529 1 9 26
3034 1 43 129
3539 4 120 340
4044 9 238 652
4549 3 347 993
5054 7 492 1,300
5559 3 429 1,233
6064 6 413 1,224
6569 4 371 1,206
7074 1 493 1,455
75+ 8 1,425 4,202
All ages 47 4,382 12,767
Ages 5069 20 1,705 4,963
Notes:
1. Only Queensland, Western Australia, South Australia, and the Northern Territory have Indigenous death registration data considered to be of
a publishable standard; therefore data from these jurisdictions only are included in the analysis by Indigenous status. Queensland data are
included from 1998 onwards.
2. Australia includes all states and territories of Australia.
3. Deaths in the not stated category are included in the column for all women, but they are not included in the other columns.
Source: AIHW National Mortality Database.
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Table 54: Age-standardised and age-specific mortality rates for breast cancer in
women by Indigenous status, Queensland, Western Australia, South Australia,
Northern Territory, 19972001
Age group Indigenous Non-Indigenous Australia
04 0.0 0.0 0.0
59 0.0 0.0 0.0
1014 0.0 0.0 0.0
1519 0.0 0.0 0.0
2024 0.0 0.2 0.2
2529 1.9 0.8 0.7
3034 2.1 3.8 3.6
3539 10.1 9.8 9.0
4044 28.2 20.2 18.2
4549 12.1 31.5 29.9
5054 37.8 49.6 43.6
5559 24.0 57.4 54.2
6064 60.2 67.1 63.6
6569 56.1 68.4 69.3
7074 21.6 95.6 87.6
75+ 137.4 143.9 133.3
All ages
Crude rate 8.0 28.5 26.8
ASR(A) 21.0 27.8 25.9
95% CI 13.928.3 27.028.6 25.526.4
Ages 5069
Crude rate 41.6 58.9 55.6
ASR(A) 42.2 58.8 55.3
95% CI 24.763.5 56.361.7 53.856.8
Notes
1. Only Queensland, Western Australia, South Australia, and the Northern Territory have Indigenous death registration data
considered to be of a publishable standard; therefore data from these jurisdictions only are included in the analysis by
Indigenous status. Queensland data are included from 1998 onwards.
2. Australia includes all states and territories of Australia.
3. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population
at 30 June 2001.
4. Deaths in the not stated category are included in the column for all women, but they are not included in the other columns.
Source: AIHW National Mortality Database.
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Appendix A: Data and statistical
issues
Data sources
Multiple data sources were analysed to produce this report. These are summarised in
Table A1. All data used in this report are based on calendar years.
TableA1: Sources for data presented in this report
Indicator Description Data source
1 Participation BreastScreen Australia state and territory services
2 Cancer detection BreastScreen Australia state and territory services
3 Sensitivity BreastScreen Australia state and territory services
4 DCIS detection BreastScreen Australia state and territory services
5 Recall to assessment BreastScreen Australia state and territory services
6 Rescreening BreastScreen Australia state and territory services
7 Incidence (ICD 174) National Cancer Statistics Clearing House, AIHW
8 Mortality (ICD 174) National Mortality Database, AIHW
Population data
The Australian Bureau of Statistics estimated resident population (ERP) data were used to
calculate screening participation and cancer incidence and mortality rates.
Participation rates were calculated using the average of the 2000 and 2001 estimated resident
female populations. The only exceptions to this were participation rates by socioeconomic
status, by language spoken at home, and by Indigenous status. The population data on
which the participation rates are based are found on the web site of the Australian Institute
of Health and Welfare at (http://www.aihw.gov.au). The ABS does not calculate ERP by
socioeconomic status or language spoken at home. In these cases the denominator was
calculated by applying the age-specific distribution of socioeconomic status and language
spoken at home from the most recent ABS Census data available to the relevant age-specific
ERP counts. For language spoken at home, the most recent available data were from the 2001
ABS Census and for socioeconomic status, the most recent available data were from the 1996
ABS Census.
The most recent direct count of the Aboriginal and Torres Strait Islander population was
carried out in the 2001 Census. However, adjustments to the Aboriginal and Torres Strait
Islander population based on the 2001 Census for years prior to 2001 were not available at
the time of publication. Consequently, projected estimates based on the 1996 ABS Census
have been used for these years.
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Mortality Data
Mortality data in this report are given for 1987 to 2001. During this time, changes have been
made to the coding and processing of mortality data that affect the comparability of the data.
Data holdings for 19871996 were manually coded using the ninth revision of the
International Classification of Diseases (ICD-9). Data holdings for 1997 onwards have been
coded using ICD-10. These data were coded using an automated system with slightly
different coding rules.
The change to the coding and processing of mortality data has introduced a break in the data
time series. The Australian Bureau of Statistics has developed comparability factors, which
are applied to the pre-1997 data, so that a single time series may still be derived (ABS 2002).
For breast cancer, the comparability factor is close to one.
The application of a comparability factor causes the number of deaths prior to 1997 to be
non-integer. Rounding has been used to put the number of deaths into whole numbers.
Statistical analysis of BreastScreen monitoring indicators
Crude rates
A crude rate is defined as the number of events over a specified period (for example, a year)
divided by the total population at risk of the event. For example, a crude cancer incidence
rate is defined as the number of new cases of cancer in a specified period divided by the
population at risk.
Age-specific rates
An age-specific rate is defined as the number of events for a specified age group over a
specified period (for example, a year) divided by the total population at risk of the event in
that age group. Age-specific rates in this report were calculated by dividing the number of
deaths, cancer cases or women participating in the screening programs in each specified age
group by the corresponding population in the same age group.
Age-standardised rates (ASR)
Age-standardised rates enable comparisons to be made between populations which have
different age structures. This publication uses direct standardisation, in which the age-
specific rates are multiplied by a constant population. This effectively removes the influence
of the age structure on the summary rate.
The National Health Data Committee has advocated the use of the 1991 Australian total
estimated resident population as the standard population until the year 2001. As the 2001
Australian total estimated resident population is now available, mortality, incidence and
participation rates are age-standardised to this population for the first time in this report. A
comparison of participation rates age-standardised to both the 1991 and 2001 populations
revealed only slight differences. For statistics based on the population of women screened
that is, cancer detection rates, interval cancer rates and program sensitivityrates are
standardised to the 1998 population of women screened by BreastScreen Australia. The
standard populations used in this report are found on the AIHW web site
(http://www.aihw.gov.au).
The method used for all these calculations consists three steps:
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Step 1: Calculate the age-specific rate for each age group.
Step 2: Calculate the expected number of cases in each five-year age group by
multiplying the age-specific rates by the corresponding standard population and
dividing by the appropriate factor (that is, 100,000 for mortality and incidence rates,
10,000 for cancer detection and sensitivity rates and 100 for the participation rate).
Step 3: Sum the expected number of cases in each age group, divide by the total of the
standard population and multiply by the appropriate factor (that is, 100,000 for
mortality and incidence rates, 10,000 for cancer detection and sensitivity rates, and
100 for the participation rate). This gives the age-standardised rate.
Rate denominators
Death rates and cancer incidence rates are expressed in this report as annual rates per
100,000 population. Rates for cancer detection are calculated per 10,000 women screened.
Screening participation rates are expressed as a percentage of the eligible population.
Rescreen and recall to assessment rates are expressed as a percentage of women screened.
Confidence intervals
The 95% confidence intervals in this report were calculated using the software package
Palisade @Risk (http://www.palisade.com). The calculations were based on
1000 simulations using a binomial or Poisson distribution with parameters calculated from
the observed data. The confidence intervals represent a range of values within which the
true value of the rate is likely to fall in 95% of iterations.
The confidence intervals are used to provide an approximate indication of the differences
between rates. Where the confidence intervals of two rates do not overlap, the
corresponding rates are statistically significantly different from each other. This is used to
compare individual stratified rates with the all-Australia rate. To be truly rigorous, such a
comparison should be between a given rate and the rate calculated from the all-Australia
data excluding the data underlying the specific rate in the comparison. Presentation of such
a comparison in this report would, however, be unnecessarily complex. The approximate
comparisons presented might understate the statistical significance of some differences, but
they are sufficiently accurate for the purposes of this report.
As with all statistical comparisons, care should be exercised in interpreting the results of the
comparison. If two rates are statistically significantly different from each other, this means
that the difference is unlikely to have arisen by chance. Judgement should, however, be
exercised in deciding whether or not the difference is of any practical significance.
Stratification variables
The data in this report are presented stratified by the age of the women at the time of
screening (for the screening data), at the time of diagnosis (for the cancer incidence data) or
at the time of death (for the cancer mortality data). A number of stratification variables
apply to some or all of the data presented:
 state or territory;
 geographic location;
 socioeconomic status;
 Indigenous status;
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 main language spoken at home;
 tumour size; and
 screening round.
State or territory
The state or territory reported is the one where screening took place (for the screening data)
or where the diagnosis was made (for the cancer incidence data) or where the death was
registered (for the cancer mortality data).
This means that it is possible for a woman to be double-counted in the screening data. If she
was screened in one jurisdiction and then screened again less than two years later in another
jurisdiction, both screens may be included in the participation rate. This should, however,
have a negligible effect on the reported participation rates.
Geographic location
Analysis of mortality data by geographic area uses the Rural, Remote and Metropolitan
Areas (RRMA) classification. This classification, developed in 1994 by the then Department
of Primary Industries and Energy and the then Department of Human Services and Health,
is used as a framework for examining breast cancer mortality data at the national level.
Seven categories are includedtwo metropolitan, three rural and two remote (see Table A2).
Table A2: Structure of the Rural, Remote and Metropolitan Areas classification
Zone Category
Metropolitan Capital cities
Other metropolitan centres (urban centre population > 100,000)
Rural Large rural centres (urban centre population 25,00099,999)
Small rural centres (urban centre population 10,00024,999)
Other rural areas (urban centre population <10,000)
Remote Remote centres (urban centre population > 5,000)
Other remote areas (urban centre population <5,000)
A more recent geographic classification system has been developed using 1996 Population
Census data. This system, known as the Accessibility/Remoteness Index of Australia
(ARIA) , categorises areas according to their distance from service centres. Service centres
are urban centres with a population of 5,000 or more as at the 1996 Census. The ARIA
system classifies areas as highly accessible, accessible, moderately accessible, remote and
very remote.
The ARIA system was not designed as a replacement for the RRMA classification. In
particular, it does not allow a comparable categorisation. Accessibility is judged purely on
distance to an urban centre. For example, Albury, Tamworth and Inner Sydney all have the
same classification (highly accessible) using the ARIA system. An updated
rural/remote/metropolitan categorisation is being developed using ARIA. Until that new
categorisation becomes available, the existing RRMA system will continue to be used.
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The RRMA classification is based on statistical local areas (SLA) and allocates each SLA in
Australia to a category based primarily on population numbers and an index of remoteness
(DPIE & DHSH 1994). Both the size of SLAs and the distribution of population within them
vary considerable. This can mean that within a remote SLA there are pockets that are rural
rather than remote and vice versa.
The use of SLAs for coding geographic regions is not straightforward. In particular, SLA
boundaries change over time. Coding data to SLAs thus raises difficulties with tracking
these changes over time and ensuring that all data are coded consistently. Instead, for this
report the data were coded to postcode and a concordance was developed to map postcode
to RRMA. This mapping is not exact, since SLA boundaries can cross postcode boundaries.
As a result, the proportion of each postcode that could be mapped to each RRMA category
was calculated and used to code the data.
A total of 507 of the BreastScreen screening data records had postcodes that could not be
mapped to an RRMA classification. These were allocated proportionally between the
classifications.
Socioeconomic status
Socioeconomic status was coded according to the Index of Relative Socio-economic
Disadvantage (IRSD). The IRSD is one of the socioeconomic indexes for areas (SEIFA
indexes) developed by the Australian Bureau of Statistics to categorise geographic areas
according to their social and economic characteristics.
It is important to note that the IRSD relates to the average disadvantage of all people living
in a geographic area. Hence any variability between groups based on the IRSD will probably
be smaller than if the variability had been measured between individuals.
Like the RRMA classification, the IRSD was developed for SLAs. However, as with the
RRMA coding, for this report the data were coded to postcode and a concordance was
developed to map postcode to quintile of IRSD. Again, this mapping is not exact, since SLA
boundaries can cross postcode boundaries. As a result, the proportion of each postcode that
could be mapped to each IRSD quintile was calculated and used to code the data.
A total of 304 of the BreastScreen screening data records had postcodes that could not be
mapped to an IRSD quintile. These were allocated proportionally between the quintiles.
Indigenous status
The BreastScreen Australia Data Dictionary (AIHW & DoHA forthcoming) specifies that
Indigenous status should be coded as
 Aboriginal;
 Torres Straits Islander;
 both Aboriginal and Torres Strait Islander;
 not indigenous; or
 not stated.
For the purposes of this report these categories were amalgamated and the data stratified
into three categories:
 Indigenous;
 not Indigenous; or
 not stated.
112
Main language spoken at home
The BreastScreen Australia Data Dictionary (AIHW & DoHA forthcoming) recommends that
main language spoken at home be coded according to the four digit ABS Australian
Standard Classification of Languages, 1998 (ABS cat. no. 1267.0). This report has collapsed
the classification into the simple dichotomy of English and Other language.
Although this stratification is reported as main language spoken at home, practice varies
between the jurisdictions as to how this information is collected. In some jurisdictions there
may thus be some lack of comparability with the BreastScreen Data Dictionary definition of
main language.
In addition, some jurisdictions do not use the Not stated classification. If main language
spoken at home is not given, it is set to a default value. The default used is not the same for
all jurisdictions. This means that the analysis based upon main language spoken at home
should be interpreted with caution.
Tumour size
Tumour size is the size in millimetres of the malignant lesion, and applies to invasive
cancers only. For more details about this stratification, see the definition given in the
BreastScreen Australia Data Dictionary (AIHW & DoHA forthcoming).
Screening round
The BreastScreen Australia Data Dictionary distinguishes between a womans screening
round in the national program and her round in the state or territory program. Round in the
national program is used for this stratification in this report. However, it is not always
possible to determine round in the national program, so for some women this stratification
has been collected as round number in the state or territory program.
BreastScreen Australia Data Dictionary
A data dictionary has been developed for the BreastScreen Australia Program (AIHW &
DoHA forthcoming). Summary definitions of key concepts and terminology used in this
report are given in the glossary. More detailed definitions and explanations may be found in
the data dictionary.
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Abbreviations
AACR: Australasian Association of Cancer Registries
ABS: Australian Bureau of Statistics
ACT: Australian Capital Territory
AIHW: Australian Institute of Health and Welfare
AHMAC: Australian Health Ministers Advisory Council
ASR: age-standardised rate
ASR(A): age-standardised ratestandardised to the Australian standard population
BSA: BreastScreen Australia
BSANAC: BreastScreen Australia National Advisory Committee
CI: confidence interval (see glossary)
DoHA: Australian Government Department of Health and Ageing
DCIS: ductal carcinoma in situ
DHSH: Department of Human Services and Health (1994 to 1996)
ERP: estimated resident population
NBCC: National Breast Cancer Centre
NHS: National Health Survey
NQMC: National Quality Management Committee
NSW: New South Wales
NT: Northern Territory
Qld: Queensland
SA: South Australia
SES: socioeconomic status
SLA: statistical local area
Tas: Tasmania
Vic: Victoria
WA: Western Australia
WHO: World Health Organization
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Glossary
Administrative databases: observations about events that are routinely recorded or required
by law to be recorded. Such events include births, deaths, hospital separations and cancer
incidence. Administrative databases include the National Mortality Database, the National
Hospital Morbidity Database and the National Cancer Statistics Clearing House Database.
Age-specific rate: a rate for a specific age group. The numerator and denominator relate to
the same age group.
Age-standardised rate: weighted average of age-specific rates according to a standard
distribution of the population by age to eliminate the effect of different age distributions and
thus facilitate valid comparison of groups with differing age compositions.
Assessment: further investigation of a mammographic abnormality or symptom reported at
screening. This includes women who choose assessment outside the Program.
Benign: not cancerous.
Cancer (malignant neoplasm): a term used to describe one of several diseases that result
when the process of cell division, by which tissues normally grow and renew themselves,
becomes uncontrolled and leads to the development of malignant cells. These cancer cells
multiply in an uncoordinated way, independently of normal growth control mechanisms, to
form a tumour. The tumour can expand locally by invasion or systemically by metastasis via
the lymphatic or vascular systems. If left untreated, most malignant tumours eventually
result in death.
Cancer death: a death where the underlying cause is indicated as cancer. People with cancer
but dying of other causes are not counted in the death statistics in this publication.
Confidence interval: a range determined by variability in data, within which there is a
specified (usually 95%) chance that the true value of a calculated parameter (for example,
relative risk) lies.
Core biopsy: removal of a cylindrical sample of breast tissue under a local or general
anaesthetic through a needle for microscopic examination.
Data: refers to the building blocks of health information, including observations from
administrative databases and health survey data sets.
Ductal carcinoma in situ: a non-invasive tumour of the mammary gland (breast) arising
from cells lining the ducts.
Early review: a woman is screened but not cleared for routine rescreening and instead is
referred for further assessment within 6 to 12 months of the index screen.
Epidemiology: the quantitative study of the distribution and determinants of health-related
states and events in populations and the application of this study to the control of health
problems.
False negative: means that the test has incorrectly observed that the disease is not present.
False positive: means that the test has incorrectly observed that the disease is present.
Film reading: viewing of a radiographic depiction of the breast (a mammogram) to
determine the presence or absence of an abnormality indicative of a tumour.
Fine needle aspiration biopsy: the sampling of cells from breast tissue for examination by a
pathologist.
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Incidence: see New cancer case.
Index screening year: the year for which the interval cancer rate and the program sensitivity
rate are determined.
Index screens: all screening examinations performed within the index screening year.
Indicators: observations about data that have been analysed to provide a means of
comparing measures of health within and between population groups.
Indigenous: a person of Aboriginal and/or Torres Strait Islander descent who identifies as
an Aboriginal and/or Torres Strait Islander person and is accepted as such by the
community with which he or she is associated.
Information: observations about data that have been analysed to provide a means of
comparing measures of health within and between population groups.
International Classification of Diseases: WHOs internationally accepted classification of
death and disease. The tenth revision (ICD-10) is currently in use.
Interval cancerinvasive (as defined for national reporting purposes by Kavanagh et al.
(1999), with minor changes pending endorsement by the National Advisory Committee):
• an invasive breast cancer diagnosed after completion of a negative screening episode
and before the next screening examination (within 24 months from the date of the
previous screen).
• a case of invasive breast cancer that is diagnosed at early review or in the interval
between assessment and early review, where the recommendation for early review is six
months or more from the screening date.
• breast cancer diagnosed in a woman by BreastScreen Australia within 24 months of a
negative screen (early rescreen) if the woman presents with a breast lump and/or clear
or blood-stained nipple discharge in the breast in which the breast cancer was
diagnosed; or
• an invasive breast cancer diagnosed between six and 24 months after a recommendation
for assessment is made and a woman fails to attend assessment.
Invasive cancer: a tumour whose cells have invaded healthy or normal tissue.
Lymph node: masses of lymphatic tissue, often bean-shaped, that produce lymphocytes and
through which lymph filters. These are located throughout the body.
Mammogram: a radiographic depiction of the breast.
Metastasis: the process by which a disease is transferred from one part of the body to
anotherfor example, via the lymphatic system or the bloodstream.
Mortality: see Cancer death.
New cancer case: a person who has a new cancer diagnosed for the first time. One person
can have more than one cancer and therefore may be counted twice in incidence statistics if
it is decided that the two cancers are not of the same origin. This decision is based on a series
of principles set out in more detail in a publication by Jensen et al. (1991).
Next scheduled screening examination: 24 months after previous screen unless the woman
is recommended for annual rescreening, when the next scheduled screening examination is
12 months.
Population estimates: official population numbers compiled by the Australian Bureau of
Statistics at both state and territory and statistical local area levels by age and sex, as at 30
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June each year. These estimates allow comparisons to be made between geographic areas of
differing population sizes and age structures.
Prevalence: the number of instances of a specific disease or other condition in a given
population at a designated time.
Recruitment: strategies that aim to promote participation of women in the BreastScreen
Australia Program through direct contact with women in the target age group and education
of health practitioners and the general public. Women are encouraged to attend every two
years.
Rescreening: the next screening examination after the screening episode in the index
screening year.
Risk factor: an attribute or exposure that is associated with an increased probability of a
specified outcome, such as the occurrence of a disease. Risk factors are not necessarily the
causes of disease.
Screening: the performance of tests on apparently well people in order to detect a medical
condition at an earlier stage than would otherwise be the case. As a screening test is not
intended to be diagnostic, so a person with a positive or suspicious result must be referred
for diagnosis and treatment.
Screening episode: includes screening examination and assessment. Early review within 6
12 months of an initial screen is not considered part of the screening episode.
Screening round: the first screening round is a womans first visit to a mammography
screening service; a subsequent screening round means that she has been screened before. If
she attends for the fourth screening round, she has been screened three times before.
Screening round (first): a womans first visit to a BreastScreen Australia mammography
screening service.
Screening round (subsequent): a womans visit to a BreastScreen Australia mammography
screening service when she has attended such a service before.
Sensitivity: the proportion of people with a disease who have a positive test result for the
disease.
Significant difference: where rates are referred to as significantly different, or one rate is
deemed significantly higher or lower than another, these differences are statistically
significant. Rates are deemed statistically significantly different when their confidence
intervals do not overlap, since their difference is greater than what could be explained by
chance. See confidence intervals in Appendix A for more information.
Symptom: any evidence of disease apparent to the patient. For the purposes of this report,
symptoms refer to a self-reported breast lump and/or blood-stained or watery nipple
discharge.
Torres Strait Islander: a person of Torres Strait Islander descent who identifies as a Torres
Strait Islander and is accepted as such by the community in which he or she lives.
Ultrasound: diagnostic method based on the reflection of ultrasonic sound waves generated
through scanning of, in this case, the breast. The reflections are viewed on a computer screen
or photograph and checked for variations in images.
Unit record file: observations containing person-specific records from health surveys and
administrative databases that are unanalysed and not tabulated. This is the most basic form
of data and cannot be accessed for general use without appropriate confidentiality measures
being in existence.
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Women-years at risk: all women screened in the index screening year who are resident in
the state or territory in which they are screened who have not reported a personal history of
breast cancer.
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